KELOWNA, British Columbia--Two-and-a-half million Club PenguinTM (clubpenguin.com) players embraced the spirit of the season and displayed their passion for helping others this holiday by participating in a unique online giving opportunity that let them donate virtual coins to support real world causes. The second annu
--Press Teleconference TODAY at 2:30pm (PST) LOS ANGELES--AIDS Healthcare Foundation: What: Press Teleconference Call AHF, owner of Out of the Closet reacts to West Hollywood visit by Rick Warren When: TODAY Tuesday, December 23rd 2:30 pm Pacific Time Who: Michael Weinstein, President, AIDS Healthcare Foundation Ho
-- Superior Court Judgment Commands California Department of Health to Comply with Landmark 2002 Law Providing Care for HIV-Infected Individuals, Compels State to Report Within 120 Days on Actions Taken LOS ANGELES--The Superior Court of California, County of Los Angeles has entered a judgment and will issue a writ ord
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/98a1a9/pricing_and_re imbu) has announced the addition of Decision Resources, Inc. s new report Pricing and Reimbursement of Fixed-Dose Combination Drugs in the United States to their offering. Fixed-dose combinations (FDCs) of prescripti
-- Conference Call Scheduled for Today at 11:00 am (Sydney time) * Creates one of Australia s leading biotechnology companies * Balanced portfolio of infectious disease and oncology assets with a Phase III HIV program * Progen shareholders to have the option to participate in AUD $20M buyback * Combined entity will hav
-- Alaska Tribal Health Consortium uses innovative technology to analyze native health issues across the state. ANCHORAGE, Alaska--The Alaska Native Tribal Health Consortium will publish a study in January 2009 which utilizes Geographic Information Systems (GIS) to analyze incidents of disease and injury across Alaska
-- BioAlliance Pharma s Team receives the French Engineer of the Year Award PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Dominique Costantini MD (President of the company s Ex
-- Letter of Appreciation from Director of National HIV/AIDS Council and Secretariat Acknowledges Successful Collaboration Which Resulted in 23,063 People Being Tested for HIV in Sierra Leone in the Week Leading Up to December 1, 2008 LOS ANGELES--AIDS Healthcare Foundation (AHF) is proud to announce that it has receiv
-- New Product Introduction Builds on Momentum from First Two Weeks of Sales of the (STARBUCKS)RED EXCLUSIVE Beverages Which Have Generated Contributions Equal to More Than 1.4 Million Daily Doses of Lifesaving Antiretroviral Medicine SEATTLE--Starbucks Coffee Company (Nasdaq: SBUX) announced today that beginning Janua
SAN MARINO, Calif.--Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics (OTCBB: VRAL), a biotechnology company that discovers and develops immune-based therapies. Montagnier joins a current team of esteemed advisors with diverse expertise to h
BRANFORD, Conn.--454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV variants from human samples in a recent study. The preliminar
--Letter from Movement for Democratic Change - South African Province Chairman Acknowledges Successful Collaboration, Expresses ...Hope That This Will Lead to a Positive Change as Far as Dealing with HIV and AIDS Issues by Both Our Leadership and the People That We Lead LOS ANGELES--AIDS Healthcare Foundation (AHF) is
-- Christmas Different Program Will Raise More than $100,000 By Selling Give Cards that Allow Recipients to Pick the Benefiting Charity --Mariners Church: WHAT: Mariners Church is asking its 8,000 to 10,000 members to entirely rethink Christmas in 2008 in the areas of gift-giving and volunteering to support the poor an
NEW YORK--Reportlinker.com announces that a new market research report related to the Diagnostic equipment industry is available in its catalogue. World Monoclonal Antibody Based Products Market http://www.reportlinker.com/p098405/World-Monoclonal-Antibody-Bas ed-Products--Market.html This report analyzes the worldwide
NEW YORK--Reportlinker.com announces that a new market research report related to the Laboratory equipment industry is available in its catalogue. World Clinical Chemistry Analyzers & Reagents Market http://www.reportlinker.com/p098408/World-Clinical-Chemistry-Anal yzers--Reagents-Market.html This report analyzes t
NEW YORK--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Gene Therapy Market http://www.reportlinker.com/p098244/World-Gene-Therapy--Market.ht ml This report analyzes the world market for Gene Therapy in Millions of
CHICAGO--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sara Lee Corporation (NYSE: SLE), Burger King Holdings, Inc. (NYSE: BKC)
CALVERTON, Md.--Macro was recently awarded a contract with the Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention to be the Data Coordinating Center for the National HIV Behavioral Surveillance System (NHBS) and the Medical Monitoring Project (MMP). This $4.7 million, 3-year contract enab
FT. LAUDERDALE, Fla.--AIDS Healthcare Foundation (AHF), the nation s largest non-profit HIV/AIDS organization, which operates free AIDS treatment clinics in the U.S., Africa, Central America and Asia, has been surveyed by the National Committee for Quality Assurance (NCQA) for reaccreditation and again awarded Full Acc
-- Update on Strategy Implementation and Milestone Achievement PARIS--Biocitech Life Sciences Park, France - Cellectis S.A. (Alternext: ALCLS), the genome engineering company for therapeutic, life science research and other biotechnology industries, announced today the achievement of a key milestone set at the time of
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co. , Inc. today announced that the U.S. Food and Drug Administration ( FDA ) has accepted the supplemental New Drug Application (sNDA) filing for ISENTRESS(R) (raltegravir) Tablets for standard review. The Company is seeking United St
-- 2008 Change of Pace Reveals Continuing Wage Gaps, Worsening Poverty, Rising Female Incarceration PHILADELPHIA--From the workplace to the home, from health care to the justice system, a report from WOMEN S WAY, the nation s oldest and largest women s funding federation, reveals stagnant socioeconomic standing and wor
TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it has received a Nasdaq Staff Deficiency Letter indicating that it fails to comply with Nasdaq s audit committee requirements. As a result of Mr. Paul F. Jacobson s previously-announced resignation from the Company s Board of Director
-- Online community allows participants to track their SSDI claims, learn more about their disability, find helpful resources, join online forums and more BELLEVILLE, Ill.--Allsup today introduced Allsup PlaceSM, a dynamic, free online community providing comprehensive resources, forums and information for individuals
-- Second Annual Ceremony Held at Oakland City Hall on World AIDS Day OAKLAND, Calif.--Ramsell Holding Corporation founder Sylester Flowers was honored by Get Screened Oakland on World AIDS Day - December 1, 2008, for his commitment to serving those in the community infected with the HIV/AIDS virus. The theme of the ev
-- December 10, 2008, Wyndham Grand Hotel, Puerto Rico RADNOR, Pa.--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, will make a poster presentation at this year s HIV DART
NEW YORK--Reportlinker.com announces that a new market research report related to the Digestive diseases industry is available in its catalogue. World Diabetes Diagnostics Market http://www.reportlinker.com/p092478/World-Diabetes-Diagnostics-Ma rket.html This report analyzes the worldwide markets for Diabetes Diagnosti
SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced the Company s President and CEO, Dr. Franco Lori, will be speaking at the HIV DART 2008 conference in Puerto Rico on Wednesday, December 10th. Dr. Lori s presentation, Development of VS411, a Virostatic Drug Fixed Dose Combination (FDC) Designed to
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has received a contract from Irish biotechnology firm, Celtic Bio
-- GeoVax s Dr. Harriet Robinson - a key conference speaker on the State of the Art Session VGXI Inc. s Robert J. Juba - speaker on Manufacturing a High Concentration Multi-Component DNA Vaccine International Society of DNA Vaccines Conference LAS VEGAS--GeoVax Labs, Inc. (OTCBB:GOVX), an Atlanta-based biopharmaceutica
BOSTON--The Blue Cross Blue Shield of Massachusetts Foundation has awarded $768,387 in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental illness, and sexual orientation. Eight organizations will receive
BALTIMORE--Profectus BioSciences, Inc. (Profectus), a biopharmaceutical company that develops proprietary prime/boost vaccines and small molecule to treat and prevent viral infections and cancers, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institu
Marked by a New Global Partnership and a High-Level Meeting on Girls and HIV in Senegal , World AIDS Week efforts Bring Girls to the Center of the HIV Response BEAVERTON, Ore.--Against the backdrop of World AIDS Week, the Nike Foundation has launched a global effort with government partners to put adolescent girls in d
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Condoms Market http://www.reportlinker.com/p090642/World-Condoms-Market.html This report analyzes the worldwide markets for Condoms in Million Units and Mi
-- Superior Court Rules California Has Failed to Comply with Landmark 2002 Law for Care of HIV-Infected; Six Years after Legislature First Passed AB 2197, Implementation of Lifesaving HIV Care Bill is at a Standstill LOS ANGELES--AIDS Healthcare Foundation: What: Press Teleconference Call Court Orders California to Com
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Immunoassay Instruments Market http://www.reportlinker.com/p090674/World-Immunoassay-Instruments -Market.html This report analyzes the worldwide markets fo
-- Important Findings for Treatment of One of World s Most Common Life-Threatening Liver Diseases -- FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced the publication of detailed 48-week data from two Phase III pivotal clinical trials evaluating the safety and efficacy of its once-daily
SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has rounded out its European patent portfolio with new patents in Ireland , France , Switzerland , Austria ,
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that it has released a report entitled: The Broad-Spectrum Treatment of Biological Weapons and Emerging Pandemic Threats. The report is available to be accessed online at: www.aethlonmedical.com/pdfs/BroadSpectrumTreament120308.pdf Summary of the Report
-- Article highlights The Bruckner Group s industry-leading expertise helping pharma and biotech companies develop new drugs that address payers healthcare value needs WAKEFIELD, Mass.--The Pink Sheet, one of the leading publications in the pharmaceutical and biotechnology industries, published an article in its Decemb
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) http://www.reportlinker.com/p097962/The-Clinical-Laboratory-Servi ces-
-- Latest Version Provides Large-Scale Collaborative Research Projects with Better Tools for Integrating, Sharing and Analyzing Complex Biological Data SEATTLE--LabKey Software, a leading provider of open source software that enables teams of researchers to pursue large-scale, collaborative projects, announced the rele
STANFORD, Calif.--The genome of a squirrel-sized, saucer-eyed lemur from Madagascar may help scientists understand how HIV-like viruses coevolved with primates, according to new research from the Stanford University School of Medicine. The discovery, to be published online on Dec. 1 in the Proceedings of the National A
--Highlights Two Beneficiaries of Giving Program in Honor of National AIDS Awareness Day BOULDER, Colo.--Webroot, a leading provider of security software for the consumer, enterprise and SMB markets, today announced the introduction of The Webroot(R) Charitable Giving Program for providing support to the areas of child
--Partnership will Provide W Hotel Guests and Local Loyalists with Insider Access to a World of Exclusive Music and Entertainment while Benefiting the Global Fund NEW YORK--WORLD AIDS DAY - W Hotels Worldwide today announced that it will be the official hotel partner of (RED)WIRE, the groundbreaking new online music ma
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today announced its support of rapid HIV testing initiatives taking place in more than 20 states in the U.S. and several countries globally, in recognition of World AIDS Day, commemorated annually on December 1st. Ora
--Testimonials to Help Raise Global Support for AIDS Vaccine Development NEW YORK--On the 20th anniversary of World AIDS Day, the International AIDS Vaccine Initiative (IAVI) invites individuals from around the world to show their support for the development of an AIDS vaccine by contributing their voices to a new gall
-- December 1 is World AIDS Day PHILADELPHIA--On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.or
Enthusiastic Response Greets Worldwide HIV Testing Campaign Led By AHF; 1,000 Organizations in 72 Countries Team Together to Test One Million People Worldwide November 26th – December 1st for Week of World AIDS Day LOS ANGELES--(BUSINESS WIRE)--As part of its global World AIDS Day effort to test one million people for
As Rate of New Infections in Florida Soars to More Than Sixty Percent Higher than the National Average, AHF s World AIDS Day Campaign Highlights Need for Increased Prevention, Education and Testing Efforts in the State—Now Ranked Second in the Nation in Reported AIDS Cases Wilton Manors Event is Part of AHF s Global O
LA s Power 106FM Radio Teams With AHF in Night of Round-the-Clock Free Rapid HIV Testing Starting Saturday, November 29th at 4:00pm Hollywood Event is Part of AHF s Global One Million Tests Campaign; 1,000 Organizations in 72 Countries Will Test One Million People for HIV by Monday--World AIDS Day LOS ANGELES--(BUSINES
PASADENA, Calif.--Twenty years after the first World AIDS Day, there are stories of survival and hope. Eduardo, Herbert, and Guy can celebrate another year of good health, thanks to their participation in Kaiser Permanente Southern California s HIV/AIDS Research Trials (H.A.R.T.) program. In 2007-2008, over 220 HIV inf
AHF s Current World AIDS Day One Million Tests Global Campaign Provides Roadmap for Collaborative Scale Up of Testing; 1,000 Groups in 72 Countries to Test 1M People by Monday US Largest AIDS Group Calls on Global Bodies Such As the World Health Organization , Global Fund and PEPFAR to Change Course and Direct More Fun
CHICAGO--In response to the development of an HIV and AIDS strategy by the Evangelical Lutheran Church in America (ELCA), the ELCA Conference of Bishops agreed to the presence of health screeners at its March 5-10, 2009, meeting for the purpose of providing HIV and AIDS testing to all members. The ELCA Conference of Bi
--EVENT DETAILS WHAT: The third annual Flowers Heritage Foundation Don t Turn your back on AIDS program provides an interactive environment where high school students learn information regarding teen HIV/AIDS infections, risks and prevention. Participants are given orientations by AIDS outreach educators, and are chall
-- On World AIDS Day, Monday, Dec. 1, Starbucks Extends Contribution for Every Hand-Crafted Beverage Purchased SEATTLE--Starbucks Coffee Company (Nasdaq: SBUX) announced today the first (STARBUCKS)RED EXCLUSIVE beverages will be available in participating stores in the U.S. and Canada from Thursday, November 27 thr
-- A Letter Sent Today to General Director Dr. Margaret Chan, Signed by AHF-Led Coalition of Hundreds, Urges Immediate Update of WHO Recommendations to End Sub-Standard Treatment Practice Widely-Known to Cause Drug Resistance and Endanger Lives LOS ANGELES--As World AIDS Day 2008 approaches, a coalition of hundreds of
NEW YORK--The U.S. Food and Drug Administration ( FDA ) has granted SELZENTRY(TM) (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals. SELZENTRY was originally granted accelerated conditional approval in August 2007 based on 24
-- AHF Kicks Off Ambitious Global Testing Campaign for Week of World AIDS Day LOS ANGELES--As part of a groundbreaking global effort to test one million people for HIV, AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care and services to more than 86,000 individuals i
GOLDEN, Colo.--MillerCoors has teamed up with Judy Shepard to support the Matthew Shepard Foundation (MSF) and its ongoing commitment to ensure that dealing with hate is a top priority in our schools and workplaces. MillerCoors, a national sponsor of MSF, announced it will match 100% of the first $10,000 in donations t
-- Piper Jaffray Healthcare Conference MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Piper Jaffray Healthcare Conference at 12:30 p.m. (Eastern) on Tuesday, December 2, 2008 at the New York Palace Hotel in New York, New York. Mike Moran, Allion s Chairman, President and Ch
-- Family with HIV/AIDs Are Featured Speakers SAN FRANCISCO--The 15th annual World AIDS Day remembrance ceremony will be held on Monday, December 1st from 12:00 p.m. to 1:00 p.m. at the National AIDS Memorial Grove in the Golden Gate Park. This year s event marks the 27th year in the fight against AIDS and commemoratin
-- On World AIDS Day, Consider the Impact on Youth CYPRESS, Calif.--The following is an opinion editorial provided by Dr. Sam Ho, executive vice president and chief medical officer of UnitedHealthcare: With improved drugs, proper care and treatment, people with HIV are living longer and stronger lives while caring for
--$1 Million Awarded Statewide Underscores Long-Term Commitment To Community Partnerships PASADENA, Calif.--Kaiser Permanente announced today that 38 nonprofit organizations from Kern to San Diego will receive grants totaling more than $300,000 to help fund a wide range of services for people with HIV and AIDS, includi
-- Phase IIb Extension Study Reaches 96 Week Milestone MELBOURNE, Australia--Australian biotechnology company Avexa (ASX:AVX) today announced that it has completed recruitment of the first 160 patients for the two-dose component of its Phase III trial for apricitabine (ATC), with over 300 patients in the screening or d
--Workplace & Careers IV Incredibly, healthcare workers report suffering over one million injuries from conventional needles and sharps (e.g., syringes, scalpels) every year; with as many as five million needle-stick injuries gone unreported. These accidental exposures can have serious consequences, from the spread
-- Supports Continued Progress in Arcelis™ Personalized Immunotherapy Programs in HIV, Oncology and Novel Autoimmune Candidate Development DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the closing of the second and final tranche of a $35.2 million Series C financing from a top-tier, international sy
-- AHF to Unveil Its “One Million Tests” Campaign, an Ambitious Global Effort to Test One Million People Worldwide for HIV During Observation of World AIDS Day 2008 (Dec 1st) 1,000 Organizations Worldwide—Including 99 Partners in the US—Will Test a Combined Total of One Million Individuals for HIV Between Nov 26th – De
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, Ardea s president and chief executive officer will present at the 20th Annual Piper Jaffray Healthcare Conference. Presentation details are as follows: Date: | Tuesday, December 2, 2008 Time: | 9:00 a.m. Eastern Standard Time
NEW YORK--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Molecular Diagnostics Market http://www.reportlinker.com/p090566/World-Molecular-Diagnostics-M arket.html This report analyzes the worldwide markets for Molecu
SAN DIEGO--Cytori (NASDAQ:CYTX) announced today it has been informed that seven new investigator-initiated clinical studies in Japan using adipose-derived regenerative cells have been approved by local ethical committees. The approvals are at leading academic university hospitals and include a diverse group of therapeu
-- Completion of M&A in Response to Proven Success of V-Clip s Mechanism of Action to Further Research in HIV/AIDS & Other Immune Based Diseases SAN MARINO, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today announced it has completed
NEW YORK & PARIS--The Global Fund, a public/private partnership dedicated to attracting and disbursing resources to prevent and treat HIV/AIDS, tuberculosis and malaria, has chosen MS&L, one of the world s leading global communications firms, to be its communications and media relations partner. The account wil
-- Under One Roof Sponsors 28 ASOs Reaching over 10,000 Patients Living with HIV/AIDS MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it has entered into a partnership with Under One Roof to launch a Community Resource Center in San Francisco. The build-out of the new center begins this wee
-- Funding to Minimize Impact on Montana s AIDS Drug Assistance Program OAKLAND, Calif.--The Flowers Heritage Foundation announced today that this year s Bridge-the-Gap recipient is the State of Montana AIDS Drug Assistance Program (ADAP). The Bridge-the-Gap program disperses funding obtained through charitable donatio
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, In my September shareholder letter, I referenced that our organization was heading into a pivotal month as we anticipated initial Hepatitis-C (HCV
-- 1000 Activists Will Rally in Washington and March to the Barack Obama Transition Office WASHINGTON---As World AIDS Day approaches, one thousand people living with HIV, and allies including Global AIDS Alliance, from across the United States , will rally for healthcare. Info at www.100daystofightaids.org/endorsements
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. World Pharmaceuticals Market Brief http://www.reportlinker.com/p097881/World-Pharmaceuticals-Market- Brief.html The global outlook series on Pharmaceuticals provides a co
-- Contest Winners and Participants to Be Honored at Award Reception and Exhibition During World AIDS Weekend OAKLAND, Calif.--The Flowers Heritage Foundation announced today that more than 11 high schools are participating in its third annual high school art competition, Don t Turn Your Back On AIDS , to raise awarene
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b43df6/medical_anthro polo) has announced the addition of the Medical Anthropology report to their offering. This important volume includes key papers which outline the history, concepts, research findings and recent controversies in medi
-- Collaborative Antiretroviral Treatment Dedicated in Formal Ceremony Earlier this Week KATHMANDU, Nepal--Earlier this week, AIDS Healthcare Foundation (AHF), the largest AIDS group in the US, and Nepal s Ministry of Health, National Center for AIDS and STI Control (NCASC) dedicated a new Center of Excellence -a free
CLEVELAND--(BUSINESS WIRE)--The American Red Cross of Greater Cleveland today honored 10 community heroes for acts of courage and compassion to others. In addition, Dr. Delos “Toby” Cosgrove, president and CEO of Cleveland Clinic, was awarded the organization’s Community Leader Award for his humanitarian work on behalf
* Marks golden anniversary with weekend of festivities attended by representatives from three presidential families, foreign ambassadors and diplomats and other luminaries * HOPE sets sights on addressing three key global health challenges as it enters its next half century and celebrates five milestones from the last
MCLEAN, Va. & BUDAPEST, Hungary--(BUSINESS WIRE)--Genetic Immunity, a US/Hungarian clinical-stage company focused on development of nanomedicines for targeted immune amplification, today announced it has treated the first subject in a Phase II clinical study to evaluate DermaVir Patch. DermaVir Patch, the Company’s
SAN DIEGO--(BUSINESS WIRE)--Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases, today reported on recent accomplishments and financial resu
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it entered into an $8.0 million growth capital loan agreement with Oxford Finance Corporation and Silicon Valley Bank. Among its terms, the loan bears interest at 12% per annum over an approximate 3 year period and contains no financial covenants. In
* ATC provided significant and durable antiviral activity over the 48-week treatment period, with a favorable safety profile and no evidence of resistance development * Antibacterial program shows activity particularly against drug-resistant Staphylococcus pathogens Ninth International Congress on Drug Therapy in HIV I
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Vaccine Technologies and Global Markets http://www.reportlinker.com/p096550/Vaccine-Technologies-and- Global-Markets.html (Due to its length, this URL may need to be copi
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Global Pharmaceutical Markets http://www.reportlinker.com/p096616/Global-Pharmaceutical-Markets .html (Due to its length, this URL may need to be copied/pasted into your
NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. DNA Diagnostics: Technologies and Global Markets http://www.reportlinker.com/p096610/DNA-Diagnostics-Technologies -and-Global-Markets.html (Due to its length, this URL may need t
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceu industry is available in its catalogue. The Blood Industry http://www.reportlinker.com/p096627/The-Blood-Industry.html The goal of this study on the blood industry is to describe and analyze the current markets for blood pro
-- AHF Cambodia CARES Donates 20,000 Kits to Government Testing Programs and Commits to Test 10,000 Individuals; Hard-hit Country Will Test 30,000 People Throughout November PHNOM PENH, Cambodia--As part of an ambitious global effort to test one million people for HIV in observance of the One Million Tests World AIDS D
-- A Few Preventive Tips Can Lower Risks for Life-Threatening Diseases and Chronic Debilitating Illnesses BOCA RATON, Fla.--The top serious health concerns for African Americans are: * Cardiovascular Disease-The #1 killer of African Americans. * Diabetes-3.2 million African Americans have diabetes, yet more than 33% do
-- The International AIDS Vaccine Initiative Opens State-of-the-Art Laboratory in Planned New Bioscience Center in New York City NEW YORK--Today New York City Mayor Michael R. Bloomberg honored the International AIDS Vaccine Initiative (IAVI) at a ribbon-cutting ceremony for its new AIDS Vaccine Design and Development
-- The International Aids Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal The International AIDS Vaccine Initiative (IAVI) WHAT: The International AIDS Vaccine Initiative (IAVI) opens an AIDS Vaccine Design and Development Laboratory in New York City, the only facility in t
* Dell Expands the Palette of Its Art House Series with Three Exclusive (PRODUCT)RED Designs * Dell Spotlights (RED)-Inspired Artists and Their Visions in Global Gallery on Dell.com * For Each Dell (PRODUCT)RED Design Purchased, Dell Will Contribute $20 to the Global Fund, Helping to Save Lives and Eliminate AIDS in Af
-- Alaska Consignment Store Will Honor AIDS Healthcare Foundation s Federally Registered Out of the Closet Trademark for its Fundraising Non-profit Thrift Stores -- AHF Renews Call on RNC to Donate Governor s Campaign Wardrobe to AHF s Out of the Closet Chain; Since 1990, US Largest AIDS Group Has Run Popular and Award
-- Leading R&D Company Will Continue Research for Both Therapeutic and Preventative Vaccines of Chronic Viral Diseases CORRECTION...by Profectus BioSciences, Inc. BALTIMORE--Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010). The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASS
-- Rodman & Renshaw Annual Global Investment Conference SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced Chief Development Officer Dr. Michael Stevens will present a Company overview during Rodman & Renshaw s Tenth Annual Global Healthcare Conference taking place November 10 through 12, 20
-- The International AIDS Vaccine Initiative Opens State-of-the-Art AIDS Vaccine Lab at Historic Brooklyn Army Terminal --The International AIDS Vaccine Initiative WHAT: The International AIDS Vaccine Initiative (IAVI) opens a Vaccine Design and Development Laboratory in New York City, the only facility in the world ex
-- First Demonstration of Pharmacologic Approach to Enhance Immune Function Against Chronic Viral Infection via Telomerase Activation MENLO PARK, Calif.--Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data on TAT2, a small molecule telomerase activator. The studies show that human CD8+ T
ATLANTA--Inhibitex, Inc. (NASDAQ: INHX) today announced its financial results for the third quarter ended September 30, 2008. We continued to perform in line with our near-term operational and financial goals during the third quarter, stated Russell H. Plumb, President and Chief Executive Officer of Inhibitex, Inc. We
MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended September 30, 2008, which include its recent expansion into the Specialty Infusion market. As a result of the April 4, 2008 acquisition of Biomed America, Inc. ( Biomed ), the Company now operates its business
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $16.9 million for the three months ended September 30, 2008, compared to $21.4 million in revenues for the three months ended September 30, 2007. Sales of the Company s OraQuick ADV
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its financial results for the third quarter of 2008 and reviewed progress in its development programs. We continue to make progress in ou
- OraSure Sales Force Expansion will Support Hospital Customers - BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that it will begin to sell its OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test directly into the U.S. hospital market beginning in 2009.
--The International AIDS Vaccine Initiative (IAVI) WHAT: The International AIDS Vaccine Initiative (IAVI) opens an AIDS Vaccine Design and Development Laboratory in New York City, the only facility in the world exclusively devoted to the development of an AIDS vaccine. IAVI will be the first occupant of a biotechnology
WASHINGTON -- AIDS Healthcare Foundation (AHF) (http://www.aidshealth.org), the largest non-profit HIV/AIDS organization in the US which currently provides medical care and services to more than 85,000 individuals in 22 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, today commended President-e
PHILADELPHIA -- NDRI, the National Disease Research Interchange, announced that the National Institutes of Health (NIH) has awarded a $7.6 million grant to NDRI to enable the human tissue science organization to expand its core mission to collect, process, and distribute donated human tissue to hundreds of leading rese
LAUSANNE, Switzerland & MONTPELLIER, France -- A study published today online in The Journal of Experimental Medicine sheds light on the potential mechanisms responsible for the increased incidence of HIV infection that was observed in the failed STEP HIV vaccine trial in 2007. Through the development of an experim
Long-term cohorts evaluated for liver histology, including fibrosis, and viral load reduction SAN FRANCISCO -- Bristol-Myers Squibb Company (NYSE:BMY) today announced data from two separate cohort evaluations, in which long-term treatment with BARACLUDE(R) (entecavir) was associated with improved liver histology, inclu
SAN FRANCISCO -- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread (R) ( tenofovir diso
DURHAM, N.C. -- Argos Therapeutics today announced the presentation of details on the Company s dendritic cell-based immunotherapy process, Arcelis(TM), as well as new research into the potential of the cytokine IL-12 as an immunopotency marker. The Company s Arcelis(TM) technology is a proprietary platform for creatin
CHICAGO--Aetna (NYSE:AET) announced today that Earvin Magic Johnson will be the featured speaker at the first Magic@50 Community Health EXPO at the Harold Washington Cultural Center (4701 S. King Drive, Chicago, IL 60615) on Saturday, November 8th. This EXPO is free and open to the public, running from 10 a.m. to 2 p.m
NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. Medical Diagnostic Kits http://www.reportlinker.com/p096619/Medical-Diagnostic-Kits.html Describes the products that comprise the Medical Diagnostic Kits (MDK) industry Details e
NEW YORK--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products http://www.reportlinker.com/p096699/Blood-The-Worldwide-Market- for-B
-- Partnership furthers Starbucks(TM) Shared Planet(TM) Commitment to the People and Communities that Grow Its Coffee SEATTLE and NEW ORLEANS--Starbucks Coffee Company (NASDAQ: SBUX) and (RED)(TM) today announced a multi-year partnership that will give coffee lovers a chance to do good every day. Through the partnershi
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/db3f79/gene_transfer_ del) has announced the addition of the Gene Transfer: Delivery and Expression of DNA and RNA, A Laboratory Manual report to their offering. Understanding gene function and regulation requires rigorous testing in live
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer of Ardea Biosciences, will present at two upcoming investor conferences. Oppenheimer 19th Annual Healthcare Conference Date: Monday, November 3, 2008 Time: 1:20 p.m. Eastern Time Locat
-- Shame on Abbott Postcard- Arriving in Mailboxes This Week- Targets Employees Neighborhoods Via Zip Codes Gleaned from Political Campaign Contribution Records --Direct Mail Piece Features Photo of CEO Miles D. White and Timeline of Abbott s Terrible Record on AIDS, Seeks to Raise Awareness About Co. s Abuse of NAFTA
MOUNT PLEASANT, S.C.--Revolutions Medical Corporation (OTCBB: RMCP) today filed its 510k application with the Food and Drug Administration for its proprietary 3cc Rev Vac Safety Syringe. The Rev Vac safety syringe uses patented technology to draw the needle into the syringe chamber after use. This safety syringe should
-- Taiwan Trial Studies Patients Who Failed to Achieve SVR with Standard Treatment, and Complements Company s Two Other Investigations in Naïve and Previously Non-Responsive HCV Patients Currently Ongoing in Europe PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new
-- Results confirm bevirimat tablet formulation dosed twice daily achieves target plasma levels WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) announced today the bevirimat Study 204 achieved its primary objective by demonstrating bevirimat plasma levels in HIV-positive patients to be in a target range
- Phase 3 ADVANCE study of telaprevir in HCV completes enrollment - Registration program for VX-770 in cystic fibrosis being discussed with global authorities- - As of September 30, 2008, Vertex had $920 million of cash, cash equivalents and marketable securities- CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (
-- Results from MERIT ES Data Reanalysis Using Enhanced Sensitivity Tropism Test at 48 Weeks Patients taking Selzentry, in combination with Combivir (R) (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to undetectable
Since 1990s, US Largest AIDS Group Has Run Popular and Award Winning Fundraising Out of the Closet Thrift Store Chain in California and Florida under Registered Federal Trademark; AHF to Ask Governor Palin and RNC to Donate Candidate s Campaign Wardrobe to AHF s Out of the Closet Chain after Election LOS ANGELES -- AID
SAN DIEGO -- Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that additional data from a Phase 2a monotherapy study of RDEA806, our lead non-nucleoside reverse transcriptase inhibitor (NNRTI) in development for the treatment of human immunodeficiency virus (HIV), were presented at the 48th Annual ICAAC/IDSA 46th
SAN DIEGO -- Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that preliminary data were presented from an ongoing Phase 1 trial of RDEA594, its lead product candidate in development for the treatment of hyperuricemia and gout, at the 2008 American College of Rheumatology (ACR) / Association of Rheumatology Health
WASHINGTON -- In a new Phase III study that compared Merck & Co. , Inc. s HIV integrase inhibitor ISENTRESS(R) (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated (treatment-naïve) HIV-infected patients], ISENTRESS reduced HIV viral load to undetectable levels (less th
WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that data from the Company s Phase 2b study of bevirimat, Panacos lead HIV-1 Gag maturation inhibitor, was shown in an oral presentatio
NEW YORK -- Patients taking Selzentry, in combination with Combivir (R) (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to screen patients, experienced a 68 percent rate of virologic suppression to undetectable levels, according to the MERIT ES (Reanalysis of the MERIT Study with the Enhanc
WASHINGTON & TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced positive interim results from two separate phase 2 clinical trials of PRO 140 for the treatment of HIV infection. Both intravenous and subcutaneous forms of PRO 140, a novel viral-entry inhibitor, exhibited potent and pro
PRINCETON, N.J. -- Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week data from the CASTLE study, in which 74 percent of the 440 patients in the REYATAZ(R) ( atazanavir sulfate)/r arm achieved an undetectable viral load, defined as HIV-1 RNA less than 50 copies/mL, compared with 68 percent of the 443 pati
MOUNTAIN VIEW, Calif. -- Tiny Prints Inc. (www.tinyprints.com), a leading online retailer of premium, personalized stationery, recently came together to offer their time for causes that matter to their workforce through outreach programs that support both the global and local community. This year, Tiny Prints is kickin
frog design, Praekelt Foundation, iTeach, National Geographic, Nokia Siemens Networks, MTN, and Others Align for Path-Breaking Social Innovation Program Project M Designed as Scalable and Replicable Solution to Public Health Crises in South Africa and Beyond CAMDEN, Maine & JOHANNESBURG, South Africa -- Pop!Tech (w
-- Vote expands recommendation to include adults aged 19-64 who have asthma and those who smoke cigarettes WHITEHOUSE STATION, N.J.--The U.S. Centers for Disease Control and Prevention s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with ast
NEW YORK-- Bristol-Myers Squibb Company (NYSE:BMY): * Reports Broad-Based Net Sales Growth of 14% from Continuing Operations * Records Growth in GAAP Diluted EPS of $1.29 Compared to $0.43 in 2007; Includes After-Tax Gain of $0.99 Per Share From Sale of ConvaTec * Posts 2008 GAAP Diluted EPS from Continuing Operations
-- Just in Time for Halloween, New Location of World s Most Fabulous Thrift Store Opens to the Public — Stocked with Everything Needed to Create a Unique Costume -- Proceeds Benefit Nonprofit AIDS Healthcare Foundation; Ninety-Six Cents of Every Dollar Earned Goes to the Care and Treatment of People Living with HIV/AID
--Funds Raised Will Support AIDS Healthcare Foundation, a Nonprofit Provider of HIV/AIDS Testing, Treatment and Other Services LOS ANGELES--AIDS Healthcare Foundation: What: Out of the Closet s Halloween Bash at Arena Hollywood Benefiting AIDS Healthcare Foundation Featuring a silent auction, games, prizes, dancing and
SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has filed a new IND for a study to reconfirm dose ranging and to prove the principle with a randomized, double-blind placebo controlled study of Cytolin(R), the Company s first-in-class drug for treating HIV/AIDS. This comes 13 years after the first IND was issued for th
MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended September 30, 2008, after the close of U.S. financial markets on Thursday, November 6, 2008. An accompanying conference call to discuss the results will be held at 5:00 p.m. ET
* Company Announces Third-Quarter 2008 Non-GAAP EPS of $0.80, Excluding 29 Cents of Restructuring Charges; Third-Quarter GAAP EPS of $0.51 * 2008 Global Restructuring Efforts Expected to Reduce Workforce by 12 Percent; Cumulative Savings of $3.8 to $4.2 Billion Expected from 2008 to 2013 and Pretax Costs of $1.6 Billio
NEW YORK & MELBOURNE, Australia--Anadis Ltd. (ANX.AX ; ANDIY.PK; CUSIP: 032517104) announced today that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research (NCHECR) and the University of New South Wales (UNSW), both in Sydney, that their Institutional Review Board has ap
-- Team Receives Positive Feedback at ILADS Conference, Study Model Potentially Applies to HIV/AIDS and Other Immune Based Diseases SAN MARINO, Calif.--Viral Genetics, Inc. (OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled to the general public initial findings of it
-- ICF International to Lead HIV/AIDS and STD Awareness and Prevention Program FAIRFAX, Va.--Z-Tech, a subsidiary of ICF International (NASDAQ:ICFI), announced today that it was awarded a new contract by the Department of Health and Human Services (HHS) to provide regionally based technical assistance and training for
-- Announces More Than $14 Million in Grants to Partners Working to Predict and Prevent the Next Pandemic MOUNTAIN VIEW, Calif.--Google.org, the philanthropic arm of Google (NASDAQ:GOOG), has announced grants of more than $14 million to support partners working in Southeast Asia and Africa to prevent the next pandemic.
* Worldwide Net Sales up 19 Percent over the Second Quarter of 2008 * Worldwide Net Sales for the First Three Quarters of 2008, Down 37 Percent over the Same Period Last Year DURHAM, N.C.--Trimeris, Inc. (Nasdaq:TRMS) today announced worldwide net sales of FUZEON for the third quarter of 2008 were $45.5 million, down 3
-- Company committed to increasing openness, quality of health care -- -- Sponsors the Gay and Lesbian Medical Association s 26th Annual Conference, world s largest gathering of lesbian, gay, bisexual and transgender health professionals -- SAN FRANCISCO--Aetna (NYSE:AET) and the Gay and Lesbian Medical Association (GL
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that the United States Patent and Trademark Office has issued a patent covering the composition of matter of RDEA806, the Company s lead non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of patients with human immunodeficiency virus
-- New Location Opens This Saturday, October 18th Next to AHF s Popular Out of the Closet Thrift Store on Sunset Blvd. in Hollywood -- Recent TV Ad Features Actor Blair Underwood Encouraging Everyone to Fill Prescriptions at AHF Pharmacy; Ninety-six Cents of Every Dollar Earned Goes to Treating People Living with HIV/A
SAN DIEGO -- Ichor Medical Systems, whose advanced TriGrid(TM) Delivery System is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today that preliminary safety and tolerability data for a Phase I preventive HIV vaccine clinical trial being conducted at the Rockefeller Uni
SAN DIEGO--Ardea Biosciences, Inc. (Nasdaq:RDEA) announced today that it has initiated a Phase 1/2 study of RDEA119, its lead mitogen-activated ERK kinase (MEK) inhibitor for the treatment of cancer, in combination with Nexavar, which is currently approved for the treatment of unresectable hepatocellular carcinoma and
BLUE BELL, Pa.--VGX Pharmaceuticals (VGXP), a developer of DNA vaccines against cancer and infectious diseases, presented today non-human primate study data from both its PENNVAX(TM) HIV Vaccine Program and its patented CELLECTRA(R) DNA Delivery technology in two presentations at the AIDS Vaccine 2008 Conference curren
DENVER--New therapeutic drugs for life threatening disease and trauma; devices made of new materials that work with the body; a highly-sensitive detector of trace amounts of biological and chemical agents in real time; new DNA immunotherapies for HIV infection; high-protein, low-cost fish food; and, new materials for u
LA JOLLA, Calif.--Burnham Institute for Medical Research announces recent developments. $98 Million Dollar Grant Supports Drug Discovery In a time of shrinking government funding, the Burnham Institute for Medical Research has received a record $98 million grant from the National Institutes of Health (NIH) to expand th
-- Reports Further Results of Hepatitis-C Patients Treated With the Aethlon Hemopurifier(R) SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced the completion of a human safety study conducted at the Fortis Hospital in Delhi, India . The primary objective of the study was to evaluate the safety of the Aethlon
PARIS--Regulatory News: BioAlliance Pharma (Paris:BIO) was informed that a civil action was filed in Delaware by Eurofins Pharma US Holding Inc. and one of its affiliates Viralliance Inc. (Eurofins) against BioAlliance Pharma and one of its executives. The action concerns the use of intellectual property related to the
-- Company Joins the Latino Commission on AIDS in Urging All Latinos to Get Tested and Learn Their HIV Status BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, announced today its support to expand access to rapid HIV testing in recognition of National Latino AIDS Aw
-- New Sales Initiative Beginning to Yield Results PORTLAND, Ore.--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that it has received an order for 50,000 tests of its Aware™ HIV-1/2 OMT product from LifeLine Scientific, its newly appointed
-- Teensource.org, a Website Dedicated to Teen Sexual Health, Has Launched an Official YouTube Channel at http://www.youtube.com/teensource; The Teensource.org YouTube Channel Debuts Today with Educational Videos about Teen Sex Education, and Sexual Health LOS ANGELES--Teensource.org, a sexual education website that fo
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b776d8/commercial_insight) has announced the addition of the Commercial Insight: HIV - The Battle for Market Share is Getting Fiercer report to their offering. In 2007, HIV drugs achieved sales of $9.3 billion in the 7MM, growing faster t
--Significant Step in Merck s Efforts to Expand Global Access to Rotavirus Vaccine WHITEHOUSE STATION, N.J.--ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), the pentavalent rotavirus vaccine from Merck & Co. , Inc., that helps prevent rotavirus gastroenteritis in infants and children, has been awarded pre-
-- County Official Pre-empts Public Comment by Non-profit AIDS Service Provider on Disputed AIDS Pharmacy Services Contract Saying it Would Not Be Inappropriate -AHF Asserts County s Bid Process Violated Federal Regulations Under Ryan White CARE Act ORLANDO, Fla.--AIDS Healthcare Foundation (AHF), the nation s largest
-- Study Group Beginning Further Research, Which it Hopes Will Unlock Mysteries, Reconcile Debate Over Lyme Treatment, Offer Answers to Other Immune Based Diseases AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today announced it has bee
-- 100mg Tablet Formulation will Move Forward in Development -- WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced its 100mg tablet formulation of bevirimat has shown very good bioavailabi
SANTA FE, N.M.--CytoDyn, Inc. (Pink Sheets:CYDY) has relocated its business offices to 1511 Third Street, Santa Fe, NM 87505. The Company s new phone number is 505-412-6480. The FAX number remains the same: 800-417-7252. The expanded office space will accommodate the staff needed to bring CytoDyn s periodic filings up
-- Non-profit AIDS Service Provider Says Orange County Officials Violated Federal Regulations and Committed Repeated Illegal Acts; Group Claims County Places Bureaucracy Above Patient Needs ORLANDO, Fla.--AIDS Healthcare Foundation: WHAT: Press Conference--Filing of LEGAL COMPLAINT by AHF Pharmacy Against Orange County
PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, announced its collaboration to the book entitled Rediscover the pleasure of food , containing culinary recommendations and recipes targeted at cancer p
-- Month-Long Celebration Includes National Rollout of Signature Fashion Show, New Orleans Store Openings, a Customer Shopping Event and a Fashion Industry Gala NEW YORK--Macy s (NYSE:M) is celebrating an epic milestone this month as the famous retailer marks its 150th birthday on October 28. A local retail store turne
-- Print Ad-which Appeared in Saturday s Lake County News-Sun-Focuses on Abbott CEO Miles D. White and His Company s Terrible Record on AIDS -- Campaign Highlights Abbott s Latest Shameful Act: Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexico
MELBOURNE, Australia--Avexa Limited (ASX:AVX) today announced that Nathan Drona will replace Stephen Cooper as Chairman of the Board while David Bottomley and Alan Boyd represent new additions to the Board. Mr. Cooper, who was serving as interim Chairman, will be stepping down from the Board to focus on his activities
-- Temporary Stock Symbol Change Will Be Reversed WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), commented on the recent and temporary change of its quotation symbol from NNVC.OB to NNVCE.OB. The E reflects that the Company has not yet filed its Form 10-KSB, annual report to shareholders. The
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/32f8ba/thailand_pharm aceu) has announced the addition of the Thailand Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Thailand Pharmaceuticals and Healthcare Report provides independent forecasts and competi
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/867691/zimbabwe_pharm aceu) has announced the addition of the Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. BMI s Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competi
NEW YORK--Standard & Poor s announced today that it has commenced Factual Stock Report coverage on Mymetics Corporation. Mymetics Corporation (OTCBB:MYMX), is a biotechnology company focused on developing prophylactic vaccines, presently focusing on vaccines against the human immunodeficiency virus (HIV/AIDS) and m
-- Enrollment for PRO 140 phase 2 clinical studies completed -- -- Interim phase 2 results for intravenous form of PRO 140 to be presented at late-breaker ICAAC session -- -- PRO 140 phase 1b clinical study results published in Journal of Infectious Diseases -- TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (Nasdaq:
GAITHERSBURG, Md.--GenVec, Inc. (Nasdaq:GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its second option period (year three) under a previously announced, five-year contract with GenVec valued at up to $52 millio
PRINCETON, N.J.-- Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration ( FDA ) approved the use of REYATAZ(R) ( atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as par
BLUE BELL, Pa.--VGX Pharmaceuticals (VGX), a developer of DNA vaccines against cancer and infectious diseases that has entered into a definitive merger agreement with Inovio Biomedical (AMEX:INO - News), announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National
SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl today announced the Company s President and CEO, Dr. Franco Lori, will be speaking at the prestigious 2nd World Conference on Magic Bullets (Ehrlich II) in Nürnberg, Germany on Saturday, October 4th 2008. Dr. Lori will address the international conference on the su
-- AB 1894 (Krekorian, D-Burbank), Sponsored by AHF, Compels Insurers Operating in California to Cover Costs of Routine HIV Tests -- Legislation Will Help California Comply with CDC s Updated 2006 HIV Testing Guidelines Recommending Routine HIV Screening for All Individuals Ages 13 to 65 --(BUSINESS WIRE)--AIDS Healthc
WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) announced today it will present at the JMP Securities Third Annual Healthcare Focus Conference on Monday, October 6, 2008 at 11:00 a.m. (Eastern Time). Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and dis
MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Maxim Group Growth Conference at 8:30 a.m. (Eastern) on Tuesday, October 7, 2008 at the Grand Hyatt Hotel in New York, New York. Mike Moran, Allion s Chairman, President and Chief Executive Officer and Russ Fichera, Chief Finan
SEATTLE--Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company s Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development. Dr. Fletcher was appointe
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today issued a statement applauding the U.S. Congress for passage of The Veterans Mental Health and Other Care Improvements Act of 2008 (S. 2162). The bill includes a provision that repeals the 1988 Veterans Benefits
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has initiated patient enrollment in the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). The device, known as the Aethlon Hemopurifier
-- Bill Streamlines HIV Counseling and Education Services for People Who Have Previously Tested and Received Such Counseling and Preventive Education Before SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised Governor Arnold S
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/16dd16/indonesia-pharmace) has announced the addition of the Indonesia Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Indonesia has a rapidly growing population of 240 million and has witnessed many of its neighbo
-- AHF Runs Pieces Headlined GSK: Worst Drug Ads Ever. The Issue Prompts Articles in the Wall Street Journal and Philadelphia Inquirer; Subsequently, Company Pulls Ads -- AHF and Others Believe Controversial Ad Campaign Was an Attempt by GSK to Maintain Market Share, to Detriment of Patient Health LOS ANGELES--AIDS Hea
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/a7d0e3/the_antiinfect ive) has announced the addition of the The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities report to their offering. The market for anti-infectives related di
WHITEHOUSE STATION, N.J.--ISENTRESS(TM) (raltegravir), Merck s medicine for HIV/AIDS, received the Prix Galien USA 2008 Award for Best Pharmaceutical Agent, Merck & Co. , Inc. announced today. We are delighted that more than a decade of work by Merck researchers has been recognized with such a prestigious award, s
WASHINGTON -- AIDS Healthcare Foundation (AHF), the largest non-profit HIV/AIDS healthcare provider in the US which currently provides treatment, care and support services to more than 80,000 individuals in 22 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, urges the passage of the Stop AIDS in
CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that key data on sustained viral response (SVR) rates in both treatment-naive and treatment-failure genotype 1 hepatitis C (HCV) patients who received telaprevir-based treatment regimens will be presented at the 59th Annual Meeting of
-- Dr. Kamiar Alaei and Dr. Arash Alaei-Two Brothers Internationally Known for their Work on HIV/AIDS-Have Been Detained Without Charge By Iranian Officials Since June 2008 -- US Largest AIDS Group Joins International Call to Press Iranian President Mahmoud Ahmadinejad, Who is to Speak Today at the UN General Assembly
STANFORD, Calif.--A simple test given to HIV/AIDS patients in southern Africa could extend their lives by nearly a year and save health-care costs at the same time, according to a new study by researchers at the Stanford University School of Medicine and the Palo Alto Veterans Affairs Health Care System. The technique,
SAN FRANCISCO--As a world leader in organ transplantation, UCSF will celebrate its 45th year of transplantation with a week of exciting workshops, lectures and forums. Virtually every single person in this country knows someone who has end-stage organ disease and who could benefit from transplantation, said Nancy Asche
SUNRISE, Fla.--Western Union, a leading provider of global money-transfer services, announced today it has established a Quick Collect account that will allow the public in the U.S. to donate to CARE for disaster relief efforts currently underway in Haiti . Individuals and corporations wishing to donate to disaster rel
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/6766fb/germany_pharma ceut) has announced the addition of the Germany Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. Our Germany Pharmaceuticals and Healthcare Report provides independent forecasts and competitive
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the 2008 UBS Global Life Sciences Conference in New York City at approximately 2:30pm Eastern Time, (11:30am Pacific Time) on Tuesday, Septem
FT. LAUDERDALE, Fla.--September 18, 2008 marks the launch of a new national awareness initiative of The AIDS Institute entitled National HIV/AIDS and Aging Awareness Day (NHAAAD). This national campaign will highlight the complex issues related to HIV prevention, care and treatment for aging populations in the
NASSAU, Bahamas--Owen Bethel, President of Mode Iles, Ltd., founder and organizer of Islands of the World Fashion Week, announced today that the Humanitarian Designer Award will be presented to Kenneth Cole and Kenneth Cole Productions, Inc. during Islands of the World Fashion Week in November, 2008. Mr. Bethel stated
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced preliminary data of Hepatitis-C (HCV) infected patients treated with the Aethlon Hemopurifier(R), a medical device designed to assist the immune response in combating infectious disease. The HCV treated patients were among end-stage renal disease (kidney di
LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments globally, AIDS Healthcare Foundation (AHF), which operates three free treatment clinics in Mexico (Puerto Vallarta, Cancun and Tuxtla Gutierrez) today unveiled a new print advertisement criticizing
-- MidCap Event PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris: FR0010095596-BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced that it will participate in the MidCap Event, a forum dedicated to meetings between i
WASHINGTON--Rose Garden 11:00 A.M. EDT PRESIDENT BUSH: Good morning. I m pleased to be here with my friend, the President of Ghana , John Kufuor of Ghana. We just had a very good discussion and before I summarize it I do want to say a word about the U.S. economy. I know Americans are concerned about the adjustments tha
SACRAMENTO, Calif.--Today, California s leading HIV/AIDS and healthcare experts called on the Governor to sign AB 1894 (authored by Assembly Member Paul Krekorian) in light of new data from the Centers for Disease Control and Prevention (CDC). This August, the CDC announced that the United States has been under-est
-- Financial Impact Estimated at $2.0 Million for 2009 ELMSFORD, N.Y.--BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE: UHG) company, has notified the Company of its intention to internalize services for HIV/AIDS and Solid Organ Transplant drugs for United members effecti
-- Gift from Undisclosed Source Will Go towards Study Which Researchers Hope Will Reconcile Long-Standing Debate over Treatment of Lyme Disease AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has completed an initial st
NEW HAVEN, Conn.--The Association of Hole in the Wall Camps had another successful camp season, largely exceeding the number of children who attended camp last year. This summer, five camps in the United States and five camps in Europe, as well as programs in Africa and Southeast Asia, provided opportunities for childr
-- AGS-003 to be tested in combination with sunitinib DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a trial of its AGS-003 therapy, in combination with sunitinib, for the treatment of newly diagnosed advanced renal cell carcinoma (RCC). AGS-003 is a product of the Company s Arcelis(TM) tec
MIRAMAR, Fla.--Altor BioScience Corporation (Altor) today announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by HIV and Hepatitis C Virus (HCV). The license has resulte
-- Cardmember Vote Will Determine Which Projects Advance to Top Five NEW YORK--American Express unveiled today the top 25 projects selected as semi-finalists for Members Project (www.membersproject.com), the online initiative that invites Cardmembers to come together to submit, discuss and vote for projects to make a p
-- Twenty-Five Innovators From Around the World Recognized for Developing and Applying Technology to Benefit Humanity SAN JOSE, Calif.--The Tech Awards, presented by Applied Materials (Nasdaq:AMAT), and a signature program of The Tech Museum of Innovation, today announced the 2008 Tech Awards Laureates, 25 global innov
MINNEAPOLIS--Minneapolis Convention Center 3:06 P.M. CDT MRS. BUSH: Thank you very much, Cindy. Thanks a lot. Thank you all. Thanks to everybody who s come out today to put these kits together. Thank you all. Thanks so much. I am very happy to be here today to be with all of you as we put these kits together for World
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. To our Shareholders, September 2008 will be a pivotal month for our organization as we expect to initiate the first clinical use of our Hemopurifier(R) in HIV-infected
-- Multi-Million Dollar Campaign Aimed at Combatting Skyrocketing HIV Infection Rate among 15-24-Year-Olds NEW YORK--Yesterday, in New York City, M A C VIVA GLAM VI spokesperson, Fergie, announced 11 new grants from the M A C AIDS Fund (MAF) aimed at preventing the spread of HIV among young people, ages 15-24, who acco
MELBOURNE, Australia--Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS. The product i
MINNEAPOLIS--Crowne Plaza Hotel St. Paul, Minnesota September 1, 2008 8:41 A.M. CDT Q Tell me the challenge of balancing this convention with what s going on in the Gulf Coast. MRS. BUSH: Well, I think, you know, we ll just see how it goes. Obviously everybody here understands. I mean, people are disappointed, the dele
- OraQuick(R) HCV Test Found to Have Higher Sensitivity and Specificity Than Other Rapid HCV Tests - BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced that an evaluation by the Walter Reed Army Institute of Research of the OraQuick(R) HCV Test, currentl
WASHINGTON--Oval Office 11:50 A.M. EDT PRESIDENT BUSH: It is such an honor to welcome a man I ve come to admire a lot to the Oval Office, President Kikwete of Tanzania . He comes representing a great country. He also comes representing the African Union. And therefore, we ve had a wide-ranging discussion about our bila
-- AB 1894 (Krekorian, D-Burbank), Will Advance Fight Against HIV/AIDS in California -- Following CDC s Recent Announcement of Alarming 40% Annual Increase in HIV Incidence in the US, Legislation Will Help Communities Meet CDC s Previous 2006 Guidelines Recommending Routine HIV Testing in Clinical and Health Care Setti
REDWOOD CITY, Calif. -- Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it has been awarded a 2-year, $3.4 million grant from the United States Department of Defense1 to develop technology to advance vaccine research and development. Under
As Reported in Today s Wall Street Journal, AHF Says Recent GSK Ad Campaign is Attempt to Maintain Market Share without Regard for Patient Health; Asks HHS to Step Up Oversight in Light of FDA s Failure to Do So LOS ANGELES -- AIDS Healthcare Foundation (AHF), the largest non-profit AIDS healthcare provider in the
MINNEAPOLIS -- Contrary to what many Americans may believe, AIDS is a growing public health threat not only overseas, but right here at home. Over the next two weeks, political leaders from both parties will discuss a variety of important issues facing the United States . The Minnesota AIDS Project, the leading source
LOS ANGELES -- As a result of the determination of a young Greenberg Glusker litigator, a physical and sexual abuse victim facing grave danger if returned to her native Mexico obtained an order from a U.S. Immigration judge granting asylum in the United States . The ruling is the outcome of a multijurisdictional, ye
The patent has been validated in the main European countries and the opposition period has now expired PARIS -- Regulatory News: BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant of its main patent on
LinkMed s wholly owned subsidiary Olerup SSP AB has developed a new test that detects genetic variations in the Human Leucocyte Antigen (HLA) system that indicate risk for severe adverse reactions to Abacavir in HIV patients. The test is marketed and sold by Qiagen. Experts expect more tests for similar markers in the
-- New Tegan and Sara Video on the Way; Tegan to Appear in Against Me! Video BURBANK, Calif.--As previously reported, singer/songwriter Tegan Quin from acclaimed Canadian band Tegan and Sara and author Augusten Burroughs (Running With Scissors; A Wolf at the Table) will co-headline SPIN.com s Liner Notes, an event at H
Team Welcomes Attendees to Poster Session to Discuss Findings, Which Could Lead to Inexpensive, Effective HIV Therapy, and May Be Applicable to Autoimmune Diseases AZUSA, Calif.--Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theor
-- Firm to Launch Nationwide Series Following US Open featuring Sampras, Navratilova, Roddick, Kournikova, Bryan Brothers and More AUSTIN, Texas--ProLink Sports + Entertainment + Media (ProLink) announced today that it will serve as an event partner for two of tennis premier events: the 2008 World Team Tennis All-Star
SAN DIEGO--iTherX Pharmaceuticals Inc, a privately held biopharmaceutical company, today announced that it has appointed a Scientific and Clinical Advisory Board to assist the company in the development of its novel therapeutic agents for Hepatitis C. iTherX is pioneering the introduction of a novel class of antivirals
-- Mattel commits 2 percent of annual pre-tax profit to global philanthropic giving. EL SEGUNDO, Calif.--Highlighting a tradition of making a meaningful difference in the lives of children, Mattel, Inc. [NYSE: MAT] today announced the continuation of its commitment to the company s six Signature Partners. In 2008, Matt
GAITHERSBURG, Md.--VIRxSYS Corporation announced today that Shuyuan Zhang, PhD, has joined the company as Senior Director of Production. Zhang will focus on the development and late stage GMP manufacture of lentiviral vectors and ex vivo patient CD4 T cell transduction and expansion for HIV treatment. The Company s fir
LAKE LAS VEGAS, Nev.--The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D. MAX Equity Conference presenter profiles. For in-depth information about the event, visit
SACRAMENTO, Calif.--The ten percent Medi-Cal provider cuts that went into effect on July 1, 2008 have already created hardships throughout California for pharmacists and the patients they serve. More and more pharmacies have been forced to stop filling Medi-Cal prescriptions because pharmacies lose money on nearly ever
-- With extensive experience in global finance, Jensen will help the foundation expand its international presence NEW YORK--amfAR, The Foundation for AIDS Research, has appointed Bradley Jensen as its new chief financial officer, amfAR CEO Kevin Robert Frost announced today. Jensen comes to amfAR from the Global Allian
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, has reported initial positive safety data from its Phase IIb/IIIa clinical study of RPI-78M for treating
-- DNA Vaccine Delivery Technology Shows Promise in Inducing Stronger Immune Responses SAN DIEGO--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today it has expanded its research license with the
NEW YORK--Gamma Mu Foundation today announced the award of more than $129,000 in community service & public education grants and scholarships in support of their mission of making the world a more hospitable place for people regardless of sexual orientation, gender identity or health status. The awards serves multi
-- AB 2899 (Portantino, D-Pasadena), Sponsored by AIDS Healthcare Foundation (AHF), Overhauls Counseling Model for HIV Testing Programs; Bill Eliminates Outdated One Size Fits All Approach for More Prudent Public Health Approach SACRAMENTO, Calif.--AIDS Healthcare Foundation (AHF), the operator of the largest non-gover
-- Company Delivers More Than 100,000 Condoms to Campaigns; Encouraging Distribution in Support of Comprehensive Sexual Education BOSTON--In response to a recent report by the Centers for Disease Control regarding a sharp increase in HIV infection rates in the United States , One(R) Condoms has issued a bold challenge
CAMBRIDGE, Mass.--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), today announced key studies highlighting the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs). Th
ATLANTA--Inhibitex, Inc. (NASDAQ:INHX) today announced its financial results for the second quarter ended June 30, 2008. We are pleased and encouraged by the measurable progress we have made in all three of our core antiviral development programs during the first half of 2008, most notably the clinical advancement of o
- Important New Treatment Option for Millions in United States Affected by Life-Threatening Liver Disease - FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration ( FDA ) has granted marketing approval for
MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 8:30 a.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada. Mike Moran, Allion s Chairman, President and Chief Executive Officer and Russ Fichera
-- Presentation at the Cambridge Healthtech Institute s Advances in Cancer Vaccines Conference DURHAM, N.C.--Argos Therapeutics today announced that Dr. Fred Miesowicz, Ph.D., Chief Operating Officer, will present details on the Company s automated manufacturing process for its Arcelis(TM) platform, a technology for cr
-- The Novel Mechanism of Action of HIVCide-I Defines a New Class of Anti-HIV Drugs WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), (the Company ) said that additional biological tests and data analysis have shown that animals treated with its lead anti-HIV drug candidate, HIVCide(TM)-I, demonstrated a substa
MEXICO CITY--XVII International AIDS Conference - Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year s International AIDS Conference (IAC) held in Mexico City. Unlike previous IAC conferences, this year s event did not have a plenary sessi
-- CASTLE gender subanalysis provides largest scale information to date about boosted protease inhibitor-based combination HIV therapy in treatment-naive women Correction by... Bristol-Myers Squibb Company MEXICO CITY--Please replace the release with the following corrected version due to multiple revisions. The co
-- In its AIDS Vaccine Blueprint 2008, IAVI proposes a series of interim milestones to help overcome the biggest challenges facing the AIDS vaccine field today MEXICO CITY--With the release of its AIDS Vaccine Blueprint 2008 at the International AIDS Conference today in Mexico City, the International AIDS Vaccine Initi
-- Efficacy and Tolerability Profile Consistent With Data Seen in Approved Treatment-Experienced Indication WHITEHOUSE STATION, N.J.--ISENTRESS(R) (raltegravir), Merck & Co. , Inc. s first-in-class integrase inhibitor, in combination with two other anti-HIV medicines, reduced HIV viral load to undetectable levels (
-- Key learnings from ongoing SECURE THE FUTURE initiatives to be presented at International AIDS Conference in Mexico City MEXICO CITY-- Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb Foundation announced today the launch of the SECURE THE FUTURE(R) Technical Assistance Program (TAP), an innovat
STANFORD, Calif.--A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of
-Positive Immune Response Data Presented at XVII International AIDS Conference- XVII International AIDS Conference DURHAM, N.C.--Argos Therapeutics today announced the presentation of positive immune response data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy
-- A new innovative therapeutic immunization designed to help existing HIV and AIDS patients enjoy prolonged drug - and side effect - free periods was announced today at the AIDS 2008 conference in Mexico City MEXICO CITY--Bionor Immuno today announced that it has advanced its efforts to develop the first HIV therapeut
MEXICO CITY--AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide—including at four free treatment clinics in Mexico—lauded Merck & Company over it intention to freeze the price on its second-line antiretrovi
-- Coalicion de Activistas por el Accesso Universal en VIH/SIDA and AIDS Healthcare Foundation Cheer President s Action; Vow to Press Government to Ensure Affordable Generic AIDS Drugs MEXICO CITY--(On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon
MEXICO CITY--AIDS Healthcare Foundation: Mexico City: AIDS Marchers Demand Testing and Treatment Thousands of AIDS advocates crowded the streets of Mexico City today in a multinational march and rally, spearheaded by AIDS Healthcare Foundation, to demand Universal AIDS Action Now. In a spirited march that began at Plaz
MEXICO CITY-- These numbers are a scathing indictment of how profoundly U.S. and CDC HIV prevention efforts have failed, said Michael Weinstein, President of AIDS Healthcare Foundation, the U.S. largest AIDS organization, in a statement from Mexico City. Despite the way the CDC is spinning these new numbers-which AHF h
-- - Agreement Includes Countries in Latin America and the Asia-Pacific Region - - Under Agreement, Gilead Will Lead Regulatory and Distribution Processes - FOSTER CITY, Calif. & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Gilead Sciences , Inc. (Nasdaq:GILD) and Merck & Co. , Inc. (NYSE:MR
-- Executive Director Greg Edwards to Present Findings on Current and Re-occurring Issues that Confront Implementation of Effective HIV/AIDS Responses in the United States XVII International AIDS Conference -- WHAT: The HIV/AIDS crisis in the United States produces almost daily discussion and the never-ending publicati
-- Thousands of AIDS Advocates to March Sunday for Universal AIDS Action Now MEXICO CITY--AIDS Healthcare Foundation: Key Events Include: * AIDS MARCH & RALLY, Sunday, August 3rd-March Demanding Universal AIDS Action Now Proceeds from Plaza de la Revolucion to Zocalo Plaza, Starts at 3pm * AIDS Satellite Session- G
-- AHF Advocacy Efforts Helped Keep PEPFAR s Focus on Providing Lifesaving Treatment; Graph Shows How Funding Will Save Five to Seven Million Lives Over the Next Five Years WASHINGTON--AIDS Healthcare Foundation (AHF), hailed President Bush for signing legislation to re-authorize PEPFAR (the President s Emergency Plan
WASHINGTON--East Room 2:57 P.M. EDT MRS. BUSH: Welcome, everyone, to the White House. Thank you all very much for coming for this signing of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008. I m so glad you all are here. Americans
-- President Bush Signs Bipartisan Legislation to Reauthorize PEPFAR to Combat Global HIV/AIDS WASHINGTON--Today, President Bush signed into law H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. This legislation responds to the P
-- AIDS Drugs Cost 30 Times as Much in Mexico as in Other Latin American Countries; President Also Commits to Help Work to Overcome Barriers to Access to Care and Treatment -- Coalicion de Activistas por el Accesso Universal en VIH/SIDA Hails Meeting, Vows to Work with President to Obtain Affordable AIDS Drug Pricing a
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc., has successfully completed the Phase IIb/IIIa clinical trial of its leading drug candidate for neu
-- 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) today announced the Company s first-in-class HIV-1 maturation inhibitor, bevirimat, will be the subject of a poster and an oral presentation at the 48th Interscience Conference
GLORIETA, N.M. & NEW YORK--CytoDyn, Inc. (Pink Sheets:CYDY) has selected Target Health, Inc. for the preparation and electronic filing of CytoDyn s upcoming FDA application using Target Health s proprietary e*CRF(R) system. The advantage of Target Health is based on its core expertise in regulatory affairs and clin
CARACAS, Venezuela--Gustavo Cisneros, Chairman and Chief Executive Officer of the Cisneros Group of Companies, said today that the triumph of Dayana Mendoza, Miss Venezuela 2007, in the Miss Universe pageant held on July 14 is yet another of the many triumphs of Venezuelan women in all areas of public life. In an inter
WASHINGTON--THE PRESIDENT: Good morning. This week, Congress voted to expand a vital program that is saving lives across the developing world -- the Emergency Plan for AIDS Relief, also known as PEPFAR. I thank members of Congress from both sides of the aisle for working with my Administration to pass this important bi
WASHINGTON--James S. Brady Press Briefing Room 12:43 P.M. EDT MS. PERINO: A special welcome to the Frattos. A couple of announcements, so bear with me here. In his speech on the freedom agenda earlier this morning you heard the President discuss PEPFAR, which is the President s Emergency Plan for AIDS Relief. He noted
-- AHF Advocacy Efforts on Capitol Hill Helped Keep PEPFAR s Focus on Providing Lifesaving Treatment; Bill Moves on to President s Desk for Signature WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 79,000 individuals in 20 countries worldwide, lauded the U.S. H
Reports Broad-Based Net Sales Growth of 16% from Continuing Operations * Records Pre-Tax Earnings from Continuing Operations of $1,221 Million representing an Increase of 24% from Second Quarter 2007 * Posts Second Quarter 2008 GAAP EPS from Continuing Operations of $0.36 Compared to $0.30 in 2007, an Increase of 20%,
In Additional Subgroup Analysis, ISENTRESS Helped to Increase CD4 Cell Counts and Decrease Viral Load in Patients Predicted to be Poor Responders WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ISENTRESS(r) (raltegravir), Merck s first-in-class HIV-1 integrase inhibitor, suppressed HIV-1 viral load and increased CD4 cell co
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will report its financial results for the second quarter of 2008 after the U.S. Financial Markets close on Wednesday, July 30, 2008. Following the announ
ALAMEDA, Calif.--Celera (NASDAQ:CRA) today reported net revenues of $43.4 million for the fourth quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. The fourth quarter fiscal 2008 results included net revenues from Berkeley HeartLab, Inc. (BHL) and Atria Genetics Inc., which were acquired durin
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/b0eecf/south_africa_p harm) has announced the addition of the South Africa Pharmaceuticals and Healthcare Report Q3 2008 report to their offering. South Africa Pharmaceuticals and Healthcare Report provides independent forecasts and compe
MELVILLE, N.Y.--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended June 30, 2008, after the close of U.S. financial markets on Thursday, August 7, 2008. An accompanying conference call to discuss the results will be held at 5:00 p.m. ET; on Th
-- Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide (pounds)8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan drug designation by the European Medicines Agency (EMEA) -- If successful, MVA85A would
-- Trial Will Assess Non-Inferiority of Once-Daily Elvitegravir Compared to Twice-Daily Raltegravir FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced that it has begun enrolling patients in a Phase III clinical trial of its investigational antiretroviral agent elvitegravir (GS 9137), a novel or
--As It Stands, Senate PEPFAR Bill Raises Global AIDS Treatment Goals in Proportion to Spending Increases on HIV/AIDS; Bill Also Requires PEPFAR to Examine Per-Patient-Spending to Increase Treatment Efficiencies WASHINGTON--A chart prepared by AIDS Healthcare Foundation (AHF) (www.aidshealth.org), which provides AIDS c
DURHAM, N.C.--Trimeris, Inc. (NASDAQ:TRMS) today announced worldwide net sales of FUZEON for the second quarter of 2008 were $38.3 million, down 38 percent from $62.0 million in the second quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the second quarter of 2008 were $16.1 million, down 51 percent from
ALAMEDA, Calif.--Celera (NASDAQ:CRA) today announced that it has received marketing clearance from the U.S. Food and Drug Administration for its 510(k) submission of the ViroSeq HIV-1 Genotyping System Software v2.8. The ViroSeq HIV-1 Genotyping(TM) System is designed to detect mutations in the HIV-1 viral genome that
NEW YORK--Answers Corporation (NASDAQ: ANSW), creators of the leading answer engine offering reference site Answers.com(R) and social knowledge Q&A site WikiAnswers.com(TM), today announced its summer Charity AnswerThon, to be held July 26 - 27, 2008. The AnswerThons, held a few times each year, are organized onlin
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/0af28c/brazil_pharmac euti) has announced the addition of the Brazil Pharmaceuticals and Healthcare Report Q2 2008 report to their offering. The Brazil Pharmaceuticals and Healthcare Report provides independent forecasts and competitive i
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/8952bc/american_sexua l_be) has announced the addition of the American Sexual Behavior: Demographics of Sexual Activity, Fertility, and Childbearing report to their offering. To create this ground-breaking volume, the New Strategist edito
WASHINGTON--I thank the Senate for the strong, bipartisan vote today to pass important, life-saving legislation reauthorizing the President s Emergency Plan for AIDS Relief (PEPFAR). I appreciate the efforts of Majority Leader Reid, Senators Biden and Lugar, and all other Senators from both sides of the aisle who came
-- Senators Reference AHF s African AIDS Treatment Clients Visits to Capitol Hill in Remarks on Bill; Delegations of Doctors and AIDS Patients From Africa Met With Over 70 Senate Offices During Past Three Months to Push Legislators to Keep Focus on Lifesaving Treatment WASHINGTON--AIDS Healthcare Foundation (AHF) (www.
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/a513bf/american_healt h_d) has announced the addition of the American Health: Demographics and Spending of Health Care Consumers, 2nd Edition report to their offering. Because health care is one of the largest industries in the
WASHINGTON--Oval Office 11:18 A.M. EDT PRESIDENT BUSH: Mr. President, thank you for coming. I first started my conversation with the President by complimenting him on his leadership in the United Nations and in the region. You ve been a constructive force for peace and stability. And we talked about
-- Highly Competitive Government Award for Paris Region Recognizes Potential of Interleukin-7 as an Immunotherapy PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that OSEO, France s national agency for industrial
-- Cycling team takes three-day journey from Albany, N.Y. to Boston, MA. to raise awareness and funding on behalf of young people living with HIV and AIDS NORTHAMPTON, Mass.--The Safe Haven Project, Inc., a non-profit organization that strives to improve the physical, emotional and social well being of children and you
CAPE TOWN, South Africa--NHLS laboratories in South Africa consist predominantly of stand-alone automated systems. IT support in the majority of these laboratories is poor and constrains the use of certain equipment. In addition, 250 nationwide laboratories are allowed public access to clinical services, especially CD4
DURHAM, N.C.--Argos Therapeutics today announced that Tamara Monesmith, Director of Manufacturing and Process Development, will present details on the Company s automated approach to manufacturing personalized dendritic cell immunotherapies. The Company s advanced manufacturing process is complementary to its Arcelis(T
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/3b8522/zimbabwe_pharm aceu) has announced the addition of the Zimbabwe Pharmaceuticals and Healthcare Report Q2 2008 report to their offering. The Zimbabwe Pharmaceuticals and Healthcare Report provides independent forecasts and competiti
ALLENDALE, N.J.--Energex Systems, Inc. announced today that it has been granted approval from the Federal Food and Drug Administration ( FDA ) to utilize its experimental HemoModulation™ therapy in a clinical trial of HIV infected patients. The purpose of the study will be to demonstrate safety and monitor viral load c
- First in a series of three public forums on HIV - MINNEAPOLIS--The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, has assembled a diverse, all-star lineup for the 2008 Allan Spear Forum series that examines issues surrounding HIV policy. The first event will take place in Mi
-- Hospitals Average 1,000 Accidental Injuries Daily, Can Lead to Life-Threatening Infections; Sharps Injury Prevention Workbook and Tools to Educate Personnel on Best Practices CHARLOTTE, N.C.--More than 385,000 needlestick and other sharps-related injuries are sustained annually by hospital-based healthcare personnel
Samaritan Expects SP-6310 Study to Confirm Significant Positive Results of a Previously Conducted Phase I/II * Improvement in Immune Function * Improvement of Quality of Life LAS VEGAS--Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new
CAPE TOWN, South Africa--Infectious disease diagnostics markets across east Africa are expanding steadily. This is mainly due to the increasing number of patients on antiretrovirals (ARVs) and the scaling up of voluntary counselling and testing programmes in the region. New analysis from Frost & Sullivan (http://ww
Study Supports CDC s 2006 Recommendation for Elimination of Written Informed Consent in HIV Testing; California at Forefront of Push for Routine Screening of General Population LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increas
LUXEMBOURG & KALAMAZOO, Mich.--ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to VI to
COLLEGEVILLE, Pa., & TARRYTOWN, N.Y.--Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission. RELIS
WASHINGTON--Rose Garden 10:31 A.M. EDT THE PRESIDENT: Good morning. Next week I m going to travel to Japan for the eighth and final G8 summit of my presidency. At recent summits, G8 countries have made pledges to help developing nations address challenges, from health care to education, to corruption. Now we need to sh
LOS ANGELES--CytoDyn, Inc. (Pink Sheets: CYDY) has begun GMP manufacturing and humanization of Cytolin(C), a monoclonal antibody that uses the human immune system to control HIV infection. The murine version of this product, for which there is already considerable human experience, will be used for a fast, randomized,
-- Press Briefing by National Security Council Senior Director for Asian Affairs, Dennis Wilder; Assistant to the President for International Economic Affairs, Dan Price; and Chairman of the Council on Environmental Quality, James Connaughton on the President s Trip to Japan and the G8 Summit LITTLE ROCK, Ark.--Jam
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India . Aethlon previously disclosed plans to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV), which cau
Led by Don MacKinnon, Founder of Hear Music NEW YORK--In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this new model will create a new revenue stream for artists and labels
ATHENS, Ohio--Diagnostic HYBRIDS has received funding through the Biomedical Research Commercialization Program (BRCP) to develop more sensitive and affordable assays for the monitoring of patients infected with Human Immunodeficiency Virus (HIV) and/or Hepatitis C Virus (HCV) and to produce vaccines against influenza
-- Lancet Editorial, Remarks by Dr. Anthony Fauci Raise New Questions on HIV Numbers; Actions Highlight Failure of US HIV Prevention Efforts as CDC Continues to Stonewall Release of Crucial Data Expected to Show Far Higher Incidence of HIV Nationwide WASHINGTON--AIDS Healthcare Foundation (AHF) is calling upon the Cent
MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced the successful completion of it s annual meeting held on June 24, 2008 at which three new directors were elected to serve on its six member Board. The shareholders also approved the issuance of 6,125,448 shares of common stock reflecting the one-for-one c
WASHINGTON--Omni Shoreham Hotel 12:59 P.M. EDT THE PRESIDENT: Thank you very much. Please be seated. (Applause.) How beautiful was that? From being a homeless mother of two to introducing the President of the United States . (Applause.) There has to be a higher power. I love being with members of the armies of compassi
WASHINGTON--National HIV Testing Day is an opportunity for Americans to increase their awareness of HIV/AIDS and get tested. More than one million Americans have HIV - and a quarter of them don t even know it. Through the Ryan White HIV/AIDS program, HIV/AIDS patients can receive treatment, including life-saving drugs,
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) and the National Association of People with AIDS (NAPWA) announced today that OraSure officials will be joined by Frank Oldham, Jr., President and CEO of NAPWA, and the Honorable Johnny Ford, Mayor of Tuskegee, Alabama and Director General of the World Conference
-- Results of a Second Phase 1 Trial in Oncology Further Demonstrate the Potential of Interleukin-7 To Induce Dramatic and Prolonged CD4 and CD8 T Cell Expansion PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the
WASHINGTON--James S. Brady Press Briefing Room 12:38 P.M. EDT MS. PERINO: Hello. One announcement for you. Tomorrow President Bush will deliver remarks at the Office of Faith-Based and Community Initiatives National Conference. During his speech he will highlight the Initiative s record of helping millions in need acro
WHITEHOUSE STATION, N.J.-- Merck & Co. , Inc. announced today that the US Food and Drug Administration ( FDA ) has issued a complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL® in women ages 27 though 45. The agency issued the letter to advise that it has
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/research/33e995/european_nucle ic_a) has announced the addition of Frost & Sullivan s new report European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications to their offering. Research Overview: This Frost & Sulliv
-- The NITD and the TB Alliance s collaboration aims to move projects quickly from the research phase through the translational stage and into development Both partners will leverage their broad networks of expertise and resources to rapidly bring effective, simpler treatments to patients NEW YORK--The Global Alliance
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has entered into an agreement to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which causes Acquired Immune Deficiency Syndrome (AIDS). The Aethlon Hemopurifier(R) is a medical device cre
MINNEAPOLIS--On June 27, in cities throughout the United States , organizations will mark National HIV Testing Day to encourage everyone to receive voluntary HIV testing and counseling to know his or her status. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, offers risk as
-- Record Number of U.S. Mayors Unite to Promote HIV Screening on June 27th BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ: OSUR) and the National Association of People with AIDS (NAPWA) announced today that more than 65 mayors and/or Department of Health offices in major metropolitan cities nationwide have committ
-- AIDS Healthcare Foundation Joins Over 60 Groups in Mexican AIDS Drug Advocacy Coalition; Marchers Call on Mexico s Secretary of Health to Step Up Action on AIDS Treatment and Drug Pricing MEXICO CITY--A group of over 150 AIDS Mexican advocates and activists held a passionate protest and advocacy march yesterday in M
-- Global Birthday Wishes Campaign for Mr. Mandela s 90th Birthday is First Truly Global Charity PSMS Service Ever Launched DUBLIN, Calif.--Sybase 365, a subsidiary of Sybase, Inc. (NYSE:SY), the global leader in mobile messaging services, today announced it has partnered with 46664, Nelson Mandela s HIV/AIDS global aw
WASHINGTON--Today President George W. Bush awarded the Presidential Medal of Freedom to six individuals. The text of each recipient s citation reads as follows: Benjamin S. Carson, Sr., M.D. Dr. Benjamin Carson is a pioneer in pediatric neurosurgery, and his life is a testament to the power of education, hard work, and
PHOENIX--Lab Express, Arizona s largest independent medical testing company, is cutting the cost of their 10 minute HIV screening to just $25 (typically $89) from June 23rd to June 27th in honor of National HIV Testing Day. Doctors recommend that anyone who is sexually active and not in a monogamous relationship should
--Grant-Making Part of Week-long Giving, HIV Awareness Activities in Region from Top Global Funder --MAF: WHAT Two South African AIDS charities received a boost from the M·A·C AIDS Fund with the announcement today of two 500 000R grants, the single largest one-time gift from the South Africa affiliate of the global fun
--Twelve S. Africans Bring Columbia University, UCLA Fellowship Training to Local AIDS Programs; Gather in Johannesburg to Discuss Stigma, Gender Inequality --M·A·C AIDS Fund Marks $125M in Global Giving JOHANNESBURG, South Africa--HIV among imprisoned juveniles, teenagers and the Muslim community headlined a discussio
* FUSILEV(TM) Launch Expected in Mid-August 2008 * FUSILEV(TM) NDA Approved by the FDA On March 7th, 2008 IRVINE, Calif.--Spectrum Pharmaceuticals, Inc., (NasdaqGM: SPPI) today announced the selection of FUSILEV(TM) (levoleucovorin) for injection as the trade name for levoleucovorin, the company s proprietary drug whic
-- Nationwide Accuracy for 2007 Through May 2008 of 99.8% Reported From Over 400 Testing Sites and More Than 250,000 Tests BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that aggregate nationwide performance data for 2007 and the first five months of 2008 indicate that its widely used rapid HI
-- Results Better Than Combination Therapy in Double-Blind Animal Study WEST HAVEN, Conn. -- NanoViricides, Inc. (OTC BB: NNVC.OB), (the Company ) said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV combo cockta
-- U.S. s Largest AIDS Organization Demands Immediate Release of New AIDS Data Referred to By NIAIDS Director Dr. Anthony Fauci at U.N. AIDS Meeting Showing Higher Rate of Infection, Calls for Massive Increase in HIV Testing Nationwide NEW YORK--AIDS Healthcare Foundation (AHF) is calling for the immediate release of t
AZUSA, Calif.--Viral Genetics (Pink Sheets: VRAL) subsidiary V-Clip Pharmaceuticals has expanded the existing Exclusive License Agreement with the University of Colorado by obtaining two Exclusive Option Agreements to acquire rights for treatment and detection of several forms of cancer including lung, breast, leukemia
LA JOLLA, Calif.--The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, The National Institutes of Health: Fueling Healthcare Innovation in California, urging legislators to support increased funding for the National Institutes of Health (NIH) – the backbone of the biomedic
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will broadcast its Research and Development Day over the internet on Wednesday June 18, at 12:00 pm ET. The meeting and webcast will be hosted by Alan W.
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), today announced factors that predict treatment response to bevirimat, a novel, oral HIV maturation inhibitor. The findings were described during multiple presentations at the 17th International HIV Drug Resistance Workshop in Sitges, Spain , con
--Campaign Voiced by Superstar Kelly Rowland -- Causes Promotes Campaign to its 12 Million Subscribers LONDON & NEW YORK--MTV s Staying Alive Foundation, SpinVox and Causes on Facebook today announced the launch of their joint campaign, Stand by What You Say . The groundbreaking initiative encourages young people t
REDMOND, Wash.--Micronics, Inc., a leading provider of custom lab card design, development, and production services for the global health market, today announced that it has been awarded a $100,000 Small Business Innovation Research grant to advance its diagnostic test to detect Human Immunodeficiency Virus (HIV) at po
-- AHF s Chris Brownlie House, Formerly the First Licensed AIDS Hospice in the Nation, Now Serves Thousands as the Hub of US Largest AIDS Organization s Public Health Outreach, Providing HIV/STD Prevention, Testing and Counseling Services LOS ANGELES--AIDS Healthcare Foundation (AHF), operator of the largest non-govern
OAKLAND, Calif.--The Flowers Heritage Foundation, a non-profit dedicated to providing solutions for public health issues, today announced a two-day HIV/AIDS forum -- A Think Tank Experience - The Third Decade: New Directions and New Models in HIV Services -- on June 6 and June 7 in Oakland, CA. Key stakeholders and opi
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference in New York City. The conference will be simultaneously webcast o
WASHINGTON--Oval Office 2:13 P.M. EDT PRESIDENT BUSH: Mr. Prime Minister, thanks for coming back. I enjoyed being with you. You represent a great country. You re a good friend of the United States of America. And I appreciate -- appreciate our candid discussion of a variety of issues. First, I want to thank you and
WASHINGTON--Navy Hill 10:49 A.M. EDT THE PRESIDENT: Thank you, all. Please be seated. Mr. Secretary, thank you for your kind introduction, and thank you for inviting me to join you to break ground for the United States Institute of Peace s new home. I m really pleased to be here. I appreciate what you do to resolve con
LOS ANGELES--Following a management meeting in San Francisco on June 7, representatives of CytoDyn, Inc. (Pink Sheets: CYDY) will be meeting with Principle Investigator Dr. Jay Lalezari at Quest Clinical Research to finalize the Company s strategy for a Phase II trial of Cytolin(R). An immune therapy that uses the huma
IRVING, Texas--Exxon Mobil Corporation (NYSE:XOM) has been awarded the 2008 Malaria Award by the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria in recognition of the corporation s Africa Health Initiative and its role in the battle against malaria. The prospects for winning the fight against global epi
WAYNE, Pa.--HOPE worldwide co-founders, Robert and Patricia Gempel, transferred their leadership roles to Randy Jordan , the global charity s chief operating officer, during the organization s annual Global Summit in May. Building on 12 years of senior leadership experience with HOPE worldwide, Jordan begins his new ro
PALO ALTO, Calif.--The Healthcare Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the South African healthcare industry to be held on Wednesday, June 11, 2008 at 8:00 a.m. PST. After 1994, South Africa transformed the healthcare system with a clear political comm
MELBOURNE, Australia--Australian biotechnology company Avexa Ltd (ASX:AVX) announced today that it will collaborate with TargetDrug on its Hepatitis C virus (HCV) program. The focus will be on the development of novel lead inhibitors of HCV replication. The Company also provided an update on the progress of its Apricit
-- AIDS Healthcare Foundation Urges Drug Giants Merck, Tibotec, Pfizer and Others to Follow Suit, Suspend Price Increases and Expand Access to Lifesaving Antiretroviral Medications LOS ANGELES--AIDS Healthcare Foundation (AHF) -- the largest US-based AIDS organization and operator of free AIDS treatment clinics in the
CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has sold its rights to future royalties in Lexiva(R) and Agenerase (R) under its 1993 license agreement with GlaxoSmithKline plc (GSK) in the field of HIV protease inhibitors
--A mood of deep pessimism has spread among the international community of AIDS scientists following last year s trial failure of a promising Merck vaccine. This was only the latest in a series of setbacks in the twenty-year struggle to develop an HIV vaccine. The passion for finding an HIV vaccine resonates strongly a
--Sunday Editorial Concedes the Senator Has a Point in Striving to Preserve the Bill s Focus on Treatment --AHF Calls for Treatment Goal Increase Equal to Funding Increase. The Results? Four Million Additional Lives Saved WASHINGTON D.C.--AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in t
-- Converse s Year-Long Global Curation Project Includes Limited Edition Designed Shoes And MAKE MINE RED Design-Your-Own Options In Support of Converse (PRODUCT) RED NORTH ANDOVER, Mass.--Converse debuts the second 1HUND(RED) Artists footwear collection for Fall/Holiday 2008, the brand s unprecedented year-long global
GAITHERSBURG, Md.--VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present additional results from its Phase II trial of VRX496, an investigational gene therapy for the treatment of AIDS, at the 2008 American Society of Gene Therapy Annual Meeting in Boston, Ma
--Newspaper Ads in New Jersey, New York s Village Voice and the Washington Blade Criticize Merck for Charging Mexico Six Times More Than Other Latin American Countries for its Key AIDS Drug, Stocrin LOS ANGELES--As part of its ongoing campaign to lower drug prices and improve access to lifesaving AIDS treatments global
TEL AVIV, Israel-- Yissum, the technology transfer company of the Hebrew University of Jerusalem, introduced today a novel device that enhances the diagnostic value of saliva. Speaking at the Technology Transfer Session at the ILSI Biomed Israel 2008 conference Professor Aaron Palmon, from the Faculty of Dental Medicin
SAN DIEGO-- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that it has entered into a license agreement with Advanced BioScience Laboratories, Inc. (ABL) so that ABL may provide advanced electroporation delivery of
WASHINGTON--As Congress considers the renewal of PEPFAR (the President s Emergency Plan for AIDS Relief), the successful US global AIDS program, over the coming weeks, AIDS Healthcare Foundation (AHF) President Michael Weinstein offers the following commentary regarding what is needed in the global fight against HIV/AI
ALEXANDRIA, Va.--Black state board of education leaders from across the nation will meet to strategize about ways in which public schools can help address the HIV and STD crises among African-Americans and to highlight the clear link between risky sexual behaviors and academic performance on May 28-30, 2008 in Atlanta,
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92547) has announced the addition of Estonia Pharmaceuticals and Healthcare Report Q2 2008 to their offering Poor healthcare has been seen as a weak link in Estonia s 15-year post-Soviet economic miracle , although the government has mad
-- Presentations Highlight Advances in Rare Cell Image Cytometry in the Areas of HIV Monitoring, Identifying RSV Infections, Improved Detection of Circulating Tumor Cells and Automated F.I.S.H. Counting. HUNTINGDON VALLEY, Pa. & BUDAPEST, Hungary--Immunicon Corporation (OTCBB:IMMC) made several presentations at the
LUXEMBOURG--The multi-centre and prospective surveillance program of HIV drug resistance emergence and transmission in Thailand starts in 2008 The Thailand Centre of Excellence for Life Sciences (TCELS, Bangkok (Thailand)), TherapyEdge Inc. (TE; Boston (MA)) and Advanced Biological Laboratories (ABL), S.A (
-Phase II Clinical Trials Prove Potent Activity for SP-01A as Salvage Therapy to Treat Ever Increasing HIV Drug Resistance -Patent Covers, 1. Composition of Anti-HIV Drugs and Anti-Cortisol Compounds and 2. Method for Decreasing the Side Effects of Anti-HIV Drugs in Humans LAS VEGAS--(BUSINESS WIRE)--Samaritan Pharmace
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c92368) has announced the addition of The Global Market for Fixed-Dose Combination Drugs for Leading Diseases to their offering. The Global Market for Fixed-Dose Combination Drugs for Leading Diseases analyzes products and applications of
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc., has received approval from the Florida Department of Agriculture and Consumer Services to conduct
LOS ANGELES--CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Nader Z. Pourhassan, Ph.D., as its Chief Operating Office. Dr. Pourhassan was born in Tehran in 1963, immigrated to the United States in 1977, and became a U.S. citizen in 1991. He received his Bachelor of Science from Utah State University in 1985, his Master
REDWOOD SHORES, Calif.--Saba (NASDAQ:SABA) the premier people management software and services provider, has announced that its customer, the HIV Online Provider Education (HOPE) Program, will be featured in an upcoming Saba Webcast titled, How Online Collaboration is Changing the World-The Use of Technology for Rapid,
Despite Congress Tripling of PEPFAR Funding for Successful US Global AIDS Program, Current Re-authorization Bill Lacks Any Treatment Requirement, a Key Component to PEPFAR s Success MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5685774 --AIDS Healthcare Foundation: AfricAlive: Portraits of Succe
MELVILLE, N.Y.--Allion Healthcare (NASDAQ: ALLI) today announced that it will participate in the Seventh Annual JMP Securities Research Conference in San Francisco, May 21, 2008. Mike Moran, Allion s Chairman, President and Chief Executive Officer will give a Company presentation on Wednesday, May 21, 2008, at 4:30 PM
-- Congress Triples Funding for Successful US Global AIDS Program in Re-authorization Bill, but Removes Requirement that Any Money Be Spent on Treatment, a Key Component of PEPFAR s Success --Senators Will Announce Effort to Preserve Treatment Priority in Legislation and Push to Increase PEPFAR s Treatment Goals; Up On
OAKLAND, Calif.--Ramsell Public Health Rx today announced that it will administer a full suite of Pharmacy Benefit Management (PBM) solutions for the Bridging the Gap, Colorado (BTGC) program, a State Pharmaceutical Assistance Program (SPAP) that covers the costs of a participant s Medicare deductible, co-payment and c
SASSARI, Italy & PRINCETON, N.J.--Virostatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced it has initiated dosing of subjects in its five-arm, dose-ranging, proof of principle st
DURHAM, N.C.--Argos Therapeutics today announced the initiation of a Phase 2a proof-of-concept clinical trial to test the efficacy of its AGS-004 therapy in improving immune control of viral replication in HIV-infected adults. AGS-004 is a product of the Company s Arcelis{TM} technology, a personalized, RNA-loaded dend
-- Jenny Boyce, a Mother Living with HIV/AIDS in Durban, South Africa , Tells the Story of How Treatment Saved Her Life --Lydia Nyide Speaks About Her 11-Year-Old Granddaughter Phumla Whose Life Was Saved by Treatment WASHINGTON--Today AIDS Healthcare Foundation (AHF), launched a YouTube video to press Congress to pr
* Net sales for the quarter increased 10.7% to a record $65.3 million * Announces Opening of New Pharmacy in Seattle with Lifelong Aids Alliance * Announces settlement of Oris Litigation MELVILLE, N.Y.--(BUSINESS WIRE)--Allion Healthcare (NASDAQ: ALLI) today announced financial results for the three months ended March
MINNEAPOLIS--Each year, the Minnesota AIDS Project hosts the largest HIV fundraiser in the state. The 2008 Minnesota AIDS Walk on May 18th will be the 21st annual event to raise crucial funds to support ongoing advocacy efforts, prevention education, and services for those living with HIV in Minnesota. A total of 325 n
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today disclosed that researchers have completed in vitro studies that verify the ability of the Aethlon Hemopurifier{R} to effectively capture monkeypox virus (MPV). MPV represents a primary model to study candidate therapies for smallpox virus as research with human infect
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced quarterly revenues of $18.1 million for the three months ended March 31, 2008, compared to $20.1 million in revenues recorded for the three months ended March 31, 2007. Increased sales of the Company s O
WASHINGTON--James S. Brady Press Briefing Room 12:41 P.M. EDT MS. PERINO: Hi, how is everybody? Two announcements for you. First of all, the President is pleased that the U.S.-Russian Agreement for Cooperation in the Field of Peaceful Uses of Nuclear Energy -- also known as a 123 Agreement -- was signed today in Moscow
ANAHEIM, Calif.--With only a week away until OC AIDS Walk at Angel Stadium of Anaheim on Saturday, May 10th, event organizers are hopeful that the Walk will far exceed its goal of $750,000. Although past years has rendered it difficult for the Walk to raise over $600,000 at its former location on the campus of UC Irvin
CARNATION, Wash.--The Washington Wines Festival announced today the 2008 Wine Weekend to benefit Camp Korey and Hole in the Wall Camps. This exclusive event featuring two days of fun, relaxation and entertainment will be held July 11 & 12, 2008 at the future site of Camp Korey at Carnation Farm and will raise funds
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) today announced that pre-clinical studies have documented that the Aethlon Hemopurifier{R} is effective in capturing circulating West Nile Virus (WNV). The study data further supports the potential use of the Hemopurifier{R} as a broad-spectrum treatment against viral patho
OAKLAND, Calif.--While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers. In May, The Clorox Company will launch Clorox{R} Pro Quaternary A
WASHINGTON--Two New Hampshire students, Aditya Ashok, 17, of Nashua and Brianna Hartford, 14, of Littleton were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth
WASHINGTON--Two Vermont students, Zoe Isaacs, 16, of Sharon and Claire Trombley, 12, of Bristol were honored in the nation s capital last night for their outstanding volunteer work during the presentation of The 2008 Prudential Spirit of Community Awards. The two young people - along with 100 other top youth volunteers
WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), said that its anti-HIV drug candidates demonstrated significant therapeutic efficacy in the recently completed preliminary animal studies. The studies were performed at a Bio-Safety Level 3 Laboratory (BSL-3) facility in Boston, MA. These mouse model studies wer
WASHINGTON--Today, Global AIDS Alliance announced that nine senior religious leaders from Indiana called on Senators Obama and Clinton to declare their support for an urgent overhaul of US foreign aid. At least 425 US soldiers, 15 of them from Indiana, have died in Afghanistan and
FAIRFAX, Va.--ICF International (NASDAQ:ICFI) was selected by the U.S. Department of Health and Human Services, Office of HIV/AIDS Policy, to provide technical management and assistance to maintain and enhance its AIDS.gov Web site. Under the new contract, ICF will implement new media tools such as mobile technology, e
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Deutsche Bank Health Care Conference to be held from May 5-7, 2008 at The InterContinental Hotel in Boston, MA. Alan W. Dunton, M.D.,
MILFORD, Mass.--SeraCare Life Sciences, Inc. (SRLS:PK) today presented data demonstrating that the Company’s seroconversion panels for HIV, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) remain stable for a minimum of 25 years. This extended shelf-life expands research opportunities for biopharmaceutical customers
BETHESDA, Md.--BrowserMedia announced today the launch of the new website for The Alliance for Microbicide Development, viewable at http://www.microbicide.org. The Alliance for Microbicide Development is the leading source for trusted information on microbicide research and development. BrowserMedia s design and inform
MELVILLE, N.Y.)--Allion Healthcare, Inc. (NASDAQ: ALLI), today announced the appointment of Russell J. Fichera to the position of Senior Vice President and Chief Financial Officer, effective June 1, 2008. Russ brings to his new position a great base of experience in the healthcare sector, and a compelling record of lea
--Spicy Pickle to Donate 25% of Sales on May 1st; Monies to be Used for Meals for People Living with Life-threatening Illnesses DENVER--The Spicy Pickle{TM} fast casual restaurant at 1298 S. Broadway today announced that 25% of their food sales on Thursday, May 1st will be donated to Project Angel Heart in support of t
LITTLE ROCK, Ark.--Facebook. MySpace. LinkedIn. The social networking trend is projected to grow by an estimated 43 percent annually over the next five years (according to Forrester Research). Now a new website is leveraging this social networking phenomenon to build online communities dedicated to helping the world ar
ALEXANDRIA, Va.--Participating in AIDS Watch 2008, Catholic Charities USA s newly named National Volunteer of the Year is on Capitol Hill this week seeking a solid federal commitment to AIDS programs. Ray Suttles, a volunteer with Catholic Charities of Paterson s Hope House in New Jersey, was named Catholic Charities U
--Funds Raised Will Support Expanded HIV Testing and Statewide Medical Care --87,000 Floridians Are Infected With HIV/AIDS, South Florida Leads the Nation in New AIDS Cases --AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, April 27, 2008 Opening Ceremony: 9:15 a.m., Walk Begins: 10:00 a.m. Where:
SOUTH KENT, Conn.--Aboard Air Force One En route Hartford, Connecticut 9:52 A.M. EDT MS. PERINO: Okay. We are on our way to Connecticut, and I have a special guest with me, Admiral Tim Ziemer, who I will turn over to in a second, because he heads up the President s Malaria Awareness Initiative and was with the First La
WASHINGTON--Today, President and Mrs. Bush commemorated the second annual Malaria Awareness Day and renewed America s commitment to lead the world in turning the tide against malaria in Africa and around the world. Yesterday, Mrs. Bush joined Members of Congress to announce the formation of the Congressional Malaria Ca
FOSTER CITY, Calif.-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced that the European Commission has granted marketing authorisation for Viread {R} ( tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B in all 27 member states of the Eu
TARRYTOWN, N.Y. & COLLEGEVILLE, Pa.--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration ( FDA ) has approved RELISTOR™ (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-indu
LOS ANGELES--Scientific consensus on the prospect for development of an effective preventive AIDS vaccine is bleak, according to the results of a poll of AIDS researchers and scientists which was released earlier today. The poll of AIDS scientists offered significant additional credibility to the recent public call by
-- Eligible AIDS/HIV Patients to Receive Assistance With Pharmaceutical Expenses OAKLAND, Calif.--Ramsell Public Health Rx today announced that the company will deliver its Pharmacy Benefit Management (PBM) solution to the Texas Department of State and Health Services (DSHS) for its new State Pharmacy Assistance Progra
- Oral Presentations at EASL Following Recent CHMP Positive Opinion Support Viread as Potential New Treatment for Life-Threatening Liver Disease - EASL MILAN, Italy-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the presentation of detailed 72-week data from two pivotal Phase III clinical trials, Studies
-Interim results to be presented in late-breaker poster presentation at EASL on April 24- -Significant early on-treatment viral response from patients who previously failed therapy- MILAN, Italy--In a late-breaker poster presentation at the 43rd Annual Meeting of the European Association for the Study of the Liver (EAS
WASHINGTON--Today, the US Congress began a long overdue overhaul of the US foreign assistance process, which experts are saying is urgent if the US is to get good value-for-money in foreign aid. In the House of Representatives, the Foreign Affairs Committee heard from top experts who called for a Cabinet-Level Departme
UCKLAND, New Zealand--New Zealand emerges as one of the most affordable options for Americans and Canadians seeking medical care and treatment in a first world environment where English is the primary language, reports Medtral New Zealand, a health care organization based in New Zealand (www.medtral.com) which coordina
-- CEO Spotlights Company s Transformation from Development Stage to Commercialization of Next Generation Threat Detection Imaging Technology HERNDON, Va.--Guardian Technologies International, Inc. (OTCBB:GDTI), innovators of groundbreaking threat detection technology with critical and immediate applications for the ho
SAN DIEGO--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it will submit a contract response to a BROAD AGENCY ANNOUNCEMENT (BAA) solicitation entitled Application of Platform Technologies for the Development of Therapeutic Agents for Biodefense . This solicitation (DMID-NIAID-NIHAI20080022BARDA) represents a
DURHAM, N.C.--Argos Therapeutics today announced the closing of a $35.2 million tranched Series C financing. The financing was led by TVM Capital and included participation from new investors Mizuho Capital, Morningside Group and Japan Asia Investment Co. Existing Argos investors Lumira Capital, Forbion Capital Partner
- High sustained virologic response (SVR) rates of 61% in PROVE 1 and 68% in PROVE 2 with 24-week telaprevir-based treatment regimen - - Telaprevir first and only investigational HCV protease inhibitor in Phase 3, ADVANCE trial underway - MILAN, Italy--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced
MALVERN, Pa. & STAFFORD, England--PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens with its patented, safe, and natural antimicrobial technology, will feature its latest developments and clinical results for its proprietary Vashe Wound Therapy Solution at the Symposium o
STOCKHOLM, Sweden--Regulatory News: * Consolidated net sales were SEK 4.2 (53.3) m. * The loss after tax amounted to SEK -41.2 (-25.6) m. * Earnings per share amounted to SEK -1.98 (-1.52) m. * Cash flow from operating activities increased by SEK 29.1 m to SEK -5.5 (-34.6) m. Liquid assets amounted to SEK 323.5 (369.8)
-- Clinical Trial is Designed to Investigate Use of IL-7 in Treatment of Immunodeficient Transplant Recipients Who Are Vulnerable to a Variety of Bacterial, Viral, and Fungal Infections PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulat
CHICAGO--Zacks.com releases the latest Analyst Interview. Today s interview is with senior analyst Chris Kallos, who discusses Health Net (NYSE: HNT), Humana (NYSE: HUM) and Allion Healthcare (Nasdaq: ALLI). A synopsis of today s Analyst Interview is presented below. The full article can be read at http://at.zacks.com/
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c89284) has announced the addition of The Emerging European Molecular POC Testing Markets to their offering. Point of care (POC) diagnostics market has experienced great success due to its benefits of advanced technology, quick turnaround
PARIS--Regulatory News: BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc{TM} (miconazole Lauriad{R}), Mucoadhesive Buccal
MELBOURNE, Australia--Avexa Ltd (AVX) announced today that it has appointed Nathan Drona a Non-Executive Director of the Company. Nathan Drona is an experienced international investment banker in the life sciences industry and has successfully advised numerous companies in the US, Europe, and Australia in mergers and a
BETHESDA, Md.--National Library of Medicine, the world s largest medical library and a component of the National Institutes of Health (NIH), today opened a new interactive exhibition, Against the Odds: Making a Difference in Global Health on the NIH campus in Bethesda, Md. Against the Odds presents a look at the public
WASHINGTON--Rose Garden 2:43 P.M. EDT PRESIDENT BUSH: Thank you all. Mr. Prime Minister, welcome to the Rose Garden. Glad you re here. It s a beautiful day. I m -- been a pleasure to welcome a good friend to the Oval Office, and had a good discussion. Appreciate our special relationship with Britain, and I believe that
OAKLAND, Calif.--The Flowers Heritage Foundation today announced the giveaway of one million condoms to San Francisco Bay Area and international healthcare organizations to help in the fight against AIDS. A 2006 California Department of Health Services report states there are 142,513 adults living with AIDS in Californ
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) announced that it has received a complaint from Inverness Medical Innovations, Inc. (AMEX:IMA), Inverness Medical Switzerland GmbH and Church & Dwight, Co., Inc. (NYSE:CHD), filed in the United States District Court for the District of New Jersey, allegin
--Approval Enables Manufacturing, Marketing, Distribution and Sales throughout China Company to Hold Conference Call at 10:30 a.m. EDT Today to Discuss Developments PORTLAND, Ore--Calypte Biomedical Corporation (OTCBB:CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that its Chines
- Record Total Revenues of $1.26 Billion, Up 22 Percent over First Quarter 2007 - - Record Product Sales of $1.14 Billion, Up 36 Percent over First Quarter 2007 - - First Quarter EPS of $0.51 per Share - - First Quarter Non-GAAP EPS of $0.54 per Share, Excluding Stock-based Compensation Expense - FOSTER CITY, Calif.--(
MORRISVILLE, N.C.--Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the first quarter of 2008 were $42.7 million, down 34 percent from $64.3 million in the first quarter of 2007. Net sales of FUZEON in the U.S. and Canada for the first quarter of 2008 were $17.0 million, down 42 percent f
PORTLAND, Ore.--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that it will hold a conference call for the investment community on Thursday, April 17, 2008 at 10:30 a.m. EDT to discuss a significant international development. The call can be
FLORHAM PARK, N.J.--Whatman, the global leader in separations technology, announces a donation of Neonatal Screening Cards to the Clinton HIV/AIDS Initiative (CHAI). The Whatman 903 Neonatal Cards were donated to CHAI for the collection of blood samples for early HIV/AIDS detection in infants in connection with CHAI s
WASHINGTON--James S. Brady Press Briefing Room 12:32 P.M. EDT MS. PERINO: Let me start off just with a couple of comments about the President welcoming Pope Benedict XVI to America today. Tomorrow in his remarks, the President will say to the Holy Father that millions of Americans have been praying for his visit. He wi
GAITHERSBURG, Md.--At today s 98th Annual Meeting of the American Association of Cancer Research (AACR) in San Diego, GenVec, Inc. (Nasdaq:GNVC) presented preclinical data illustrating the activity of GenVec s lead product candidate, TNFerade{TM}, when used in combination with gemcitabine in preclinical models of pancr
MINNEAPOLIS--According to statistics released today by the Minnesota Department of Health, 325 new cases of HIV were reported in Minnesota during 2007. The Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, noted specific areas of concern including: * A total of 325 new cases of H
ATLANTA--Inhibitex, Inc. (Nasdaq: INHX), a biopharmaceutical company focused on the development of products to treat and prevent serious infectious diseases, announced that it is presenting data from a Phase I clinical study of FV-100, a highly potent antiviral compound in development for the treatment of shingles, at
WASHINGTON--In a community forum and conference call hosted today by the Federal AIDS Policy Partnership (FAPP) to discuss HIV incidence versus actual reported cases of HIV in the US and the long-awaited release of new, more closely-studied HIV data from 2005, HIV/AIDS experts participating in the call appeared to retr
WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS medical care to more than 65,000 individuals in 20 countries worldwide, today supported Senator Barak Obama s call for more widespread availability of AIDS drugs for poor patients, a call he made Sunday evening during CNN s Compassion Forum, a televised
SAN DIEGO--Brickfish{TM}, a social media advertising platform and Internet Sexuality Information Services, Inc. (ISIS), a not-for-profit organization dedicated to promoting sexual health, are inviting people to design intimate apparel to help get the word out about preventing HIV and other sexually transmitted diseases
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced that on April 10, 2008, it had acquired the remaining outstanding equity in its drug discovery holding, ReceptoPharm, Inc. ( Receptopharm ). We are extremely pleased to have
MILPITAS, Calif.--Equipped with portable electronic devices that range from high-definition camcorders to satellite-based mobile phones, a three-member climbing team sponsored by Dell (PRODUCT) RED + Windows Vista (PRODUCT) RED, MSN and MSNBC - and carrying a variety of flash-memory products from SanDisk Corporation (N
-- 87,000 Floridians Are Infected with HIV/AIDS, South Florida Leads the Nation in New AIDS Cases FT. LAUDERDALE, Fla.--AIDS Healthcare Foundation: What: Florida AIDS Walk When: Sunday, April 27, 2008 Opening Ceremony: 9:15 a.m., Walk Begins: 10:00 a.m. Where: Huizenga Plaza, Downtown Ft. Lauderdale Who: Blair Unde
LONDON--As developers of point of care (POC) molecular tests enhance their application scope to detect new disease markers, the POC molecular diagnostics market will present attractive opportunities. Market participants can enhance the utilization of POC molecular tests by improvising the existing tests and simultaneou
DEERFIELD, Ill.--Walgreens (NYSE:WAG)(NASDAQ:WAG) announced today that Walgreens Specialty Pharmacy has launched a new HIV-focused Web site, HIV.Walgreens.com, to expand the availability of HIV/AIDS information to patients and caregivers. The new site complements Walgreens Specialty Pharmacy s current HIV/AIDS patient
WASHINGTON--Six AIDS medical care providers and treatment clients from Uganda and South Africa are visiting Washington, DC this week for a series of meetings on Capitol Hill with Senate and Congressional leaders to lobby Congress as they consider bills to reauthorize PEPFAR (the President s Emergency Plan for AIDS Reli
SAN DIEGO & NAGASAKI, Japan--Nagasaki University will sponsor and perform a clinical study on the use of cell-enhanced reconstruction in HIV therapy-induced facial atrophy, a condition where adipose (fat) tissue becomes unevenly lost, leaving patients with a gaunt appearance. The study will be funded through a thre
-- Study Led by Principal Investigator Dan H. Barouch, MD, PhD, a Scientist in the Division of Viral Pathogenesis at BIDMC and Associate Professor of Medicine at Harvard Medical School SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electr
CHICAGO--Radiant Development is pleased to announce the addition of Joan L. Drucker, MD, as Chief Medical Officer. Dr. Drucker will provide medical consultation, regulatory and pharmacovigilance expertise as well as oversight for clinical studies managed by Radiant Development. Dr. Drucker possesses clinical, managemen
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c88085) has announced the addition of new Decision Resources report How to Get Ahead with Pharmacogenomics to their offering. Introduction Pharmacogenomics (PGx) is an evolutionary-not a revolutionary-process. The blockbuster business mode
BURLINGTON, Vt.--Dedicated to making poverty history, the ONE Campaign welcomed Ben & Jerry s as a partner, announcing a joint endeavor today to fight extreme poverty and preventable disease around the world. The partnership was announced at the Ben & Jerry s Scoop Shop in Burbank, California, and featured Ben
-- Diversifies payor base by increasing revenue from non-governmental payors --Acquisition anticipated to be accretive to earnings MELVILLE, N.Y.--Allion Healthcare (Nasdaq: ALLI) today announced that it has been granted early termination of the waiting period required by the Hart-Scott-Rodino Act and has closed its ac
CAMBRIDGE, Mass.--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Canaccord|Adams Hepatitis C Conference on Wednesday, April 9, 2008 at 4:00 p.m. EDT. The presentation will be webcast live and may be accessed from Events & Presentations on th
NEW YORK--SpiralFrog, Inc., (www.spiralfrog.com) the free and legal, ad-supported web-based music service, today announced it was selected by the non-profit organization, Keep a Child Alive (KCA), to be the exclusive download partner for Alicia in Africa: Journey to the Motherland, the documentary of Grammy Award-winni
WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), said that preliminary animal trials of the Company s HIV therapeutic candidates have begun at a BioSafety Level 3 (BSL-3) Laboratory facility in Boston, MA. The initial results are expected before the end of next month. These animal studies will be conducted by
WASHINGTON--A modest, 27% increase in global HIV/AIDS spending was authorized this week in an important vote in the House of Representatives. We welcome this reauthorization of the AIDS program and congratulate members for avoiding a partisan logjam on this crucial issue, said Dr. Paul Zeitz, Executive Director of the
ST. LOUIS--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the release of eight new AlphaLISA{TM} immunoassay kits in conjunction with the Society for Biomolecular Sciences (SBS) 14th Annual Conference and Exhibition. These latest innovations include research reagents an
MARLBORO, Mass.--Skyscape{R}, the worldwide leading service for trusted medical information by specialty for mobile devices announced today that it is the exclusive mobile service provider of the popular Antibiotic (ABX) and HIV Guides. Developed by the Johns Hopkins POC-IT (Point of Care Information Technology) Center
BUCHAREST, Romania--THE WHITE HOUSE Office of the Press Secretary Today the House of Representatives approved the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. This strong bipartisan vote advances the reauthorization of the life-saving work of the P
WASHINGTON--AIDS Healthcare Foundation (AHF) (www.aidshealth.org), which provides AIDS medical care to more than 65,000 individuals in 20 countries worldwide, expressed its profound disappointment with the House of Representatives for its passage today of the bill to reauthorize PEPFAR (the President s Emergency Plan f
BUCHAREST, Romania--Aboard Air Force One En route Bucharest, Romania 5:43 P.M. (Local) MS. PERINO: Let me start off by saying that we re going to Bucharest, Romania, which is always helpful to tell you where we re going. Q The President got his daily intelligence briefing. That s always good. MS. PERINO: We don t have
KIYV, Ukraine--School 57 3:56 P.M. (Local) PRESIDENT BUSH: Thank you all very much for letting Laura and me come by your school. And thank you all for coming. You did an excellent job. And we love the Peace Corps. They re great, aren t they? Listen, Laura and I are very impressed by your country. It s exciting to be in
WASHINGTON--The 2008 BIO International Convention will demonstrate the biotechnology industry s global focus with international case studies, global health breakout sessions and receptions that spotlight examples of biotechnology innovation from around the world. The BIO International Convention, hosted by the Biotechn
SAN DIEGO--PURE Bioscience (OTCBB: PURE) today announced the launch of QuikCharge{R} SDC by Earth Friendly Chemicals. The latest private label brand of PURE s patented silver dihydrogen citrate (SDC)-based disinfectant was introduced at the 2008 Pumper & Cleaner Environmental Expo, the world s biggest annual trade
COLLEGEVILLE, Pa. & TARRYTOWN, N.Y.--Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that Wyeth has received marketing approval from Health Canada , the Canadian Regulatory Agency, for RELISTOR{TM} (methylnaltrexone bromide injection) for s
DURHAM, N.C.--Argos Therapeutics today announced the presentation of positive safety and feasibility data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy (ART). AGS-004 is an adaptation of the Company s Arcelis{tm} technology, a personalized, RNA-loaded dendrit
CHICAGO--Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL bad cholesterol and greatly increases the risk for pr
ATLANTA -- In response to statements today by the AIDS Healthcare Foundation, CDC provides the following important clarification and corrections regarding CDC s 2006 HIV/AIDS Surveillance Report, published on March 26, 2008. (http://www.cdc.gov/hiv/topics/surveillance/resources/reports/ 2006report/pdf/2006SurveillanceR
AHF Calls Numbers a National Catastrophe; Notes Lifetime Costs of Treatment Will Approach $36 Billion LOS ANGELES -- AIDS Healthcare Foundation (AHF) (www.aidshealth.org) will host a press teleconference Friday March 28th at 11:00 AM Eastern Daylight Time to respond to the release of a long-awaited report by the Center
LOS ANGELES--Wearing a Christian Siriano designed couture dress, Kimberley Locke performed her new hit single Fall live on AMERICAN IDOL Wednesday, March 26 on FOX. The one-of-a-kind Siriano creation is available for auction at www.clothesoffourback.org. Funds raised through the Kimberley Locke/Christian Siriano dress
WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB), announced today that preliminary animal trials of HivCide-I{TM}, the Company s proposed HIV therapeutic, will begin soon at a BSL-3 facility in Boston, MA. The initial results are expected by the second week of May. These animal studies will be conducted by Dr.
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c86823) has announced the addition of Strategic Analysis of the South African Paediatric Vaccines Markets to their offering. This Frost & Sullivan research service titled Strategic Analysis of the South African Paediatric Vaccines Mark
NASSAU, The Bahamas--The fashion world is buzzing about Islands of the World Fashion Week (IWFW) to take place in Nassau, The Bahamas, November 5-8, 2008, set to showcase well-known and new designers from islands around the world and to promote cultural diversity and creativity. The producer of IWFW is Mode Iles, Ltd.,
MELBOURNE, Australia--Avexa Ltd (AVX) announced today that its Chairman, Dr Hugh Niall, has retired from the Board of the Company effective immediately. Non-Executive Director Mr. Stephen Cooper will assume the role of Chairman pending a search for a new Board member to assume the role of Chairman on a longer term basi
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the Company ), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it has entered into a license agreement with FirstPoint Biotech, Inc. ( FPBT ) (www.firstpointbiotech.com), a privately held biopharmace
WASHINGTON--In conjunction with today s HIV Vaccine Summit in Bethesda, Maryland, AIDS Healthcare Foundation (AHF) will host a press teleconference on Tuesday, March 25th at 12:15 P.M. (EDT) to call for the suspension of costly HIV vaccine research funding and the re-allocation of resources into effective HIV/AIDS prev
WEST HOLLYWOOD, Calif.--The City of West Hollywood will host the Gay Men s Forum: The Body and Soul of the Community on Saturday, April 19, 2008 from 9 a.m. to 5 p.m. in Fiesta Hall at Plummer Park, 7377 Santa Monica Boulevard, West Hollywood. This day-long event will focus on the theme: Where We ve Been. Where We Are.
WEST HAVEN, Conn.--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company ), announced today that Howard Fields, PhD, currently a member of the Scientific Advisory Board, will join the Company as Vice President of Virology. We re very pleased to have Dr. Fields, a scientist of great international repute, joining us. He wil
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c86494) has announced the addition of Zimbabwe Pharmaceuticals and Healthcare Report Q1 2008 to their offering. The struggling Zimbabwean economy, hyperinflation and the isolationist and internationally unacceptable government policy will
FOSTER CITY, Calif.-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion on the company s application to extend the indication for Viread [reg
WHITEHOUSE STATION, N.J.-- Merck & Co. , Inc. announced today that the U.S. Food and Drug Administration ( FDA ) has accepted, and designated for priority review, the supplemental Biologics License Application (sBLA) for GARDASIL[registered trademark] [Human Papillomavirus Quadrivalent] (Types 6, 11, 16, 18) Vaccin
Grant-Maker Calls for Applications to Address Stigma, Shame Surrounding AIDS in UK During London Expert Roundtable; [pounds]250,000 in Grants Available LONDON--The MAC AIDS Fund, the philanthropic arm of Estee Lauder-owned M·A·C Cosmetics, gathered a group of AIDS thought-leaders in London today for a discussion to pro
CHANTILLY, Va.--BIA Information Network (BIN) (http://www.activeaccess.com), a leading provider of private-label desktop applications, announced today that the American Academy of HIV Medicine (AAHIVM), an independent organization of HIV care providers dedicated to promoting excellence in HIV/AIDS care, will launch AAH
IRVINE, Calif.--The bases will be loaded as over 8,000 participants step up to the plate on Saturday, May 10th for the 22nd Annual OC AIDS Walk at Angel Stadium of Anaheim. The Walk expects to raise a Grand Slam $750,000. As registration begins at 7am, wake up as NBC4 Today In L.A. s Robert Kovacik and Legendary KLOS D
SAN DIEGO)--Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, disclosed today that its Hemopurifier{tm} treatment technology is the subject of an ABC news story. The story can be accessed online at: www.wjla.com/news/stories/0308/503883.html About Aethlon Medical
BETHLEHEM, Pa.--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Ronald H. Spair, Chief Operating Officer and Chief Financial Officer, will speak to the investment community at the Cowen & Co. Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Intern
NEW YORK--Chembio Diagnostics, Inc. (OTCBB:CEMI) announces the following Webcast: What: Lippert/Heilshorn Life Sciences Virtual Conference When: March 18, 2008 @ 10:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=127008 How: Live over the Internet -- Simply log on to the web at the address above.
BOSTON--Greater Boston s culinary community and local dignitaries will join together to host the 16th annual LifeSavor, a celebratory fundraiser, on Thursday, March 27th, at Langham Hotel Boston in downtown Boston. Sponsored by State Street Corporation, MAC VIVA GLAM, and The Langham Hotel Boston, this year s LifeSavor
WILMINGTON, Del.--Incyte Corporation (Nasdaq:INCY) will announce today at the Cowen and Company 28th Annual Health Care Conference results from its initial meeting with the U.S. Food & Drug Administration ( FDA ) regarding the development of its lead JAK inhibitor, INCB18424, for myelofibrosis. Paul Friedman, M
TARRYTOWN, N.Y.--Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its results of operations for the fourth quarter and year ended December 31, 2007. Revenues for the fourth quarter ended December 31, 2007 totaled $15.5 million compared to $21.9 million for the same quarter in 2006. For the year ended Dece
WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 65,000 individuals in 20 countries worldwide, today joined other global health advocates in praising the announcement by Thailand s new Minister of Health Chaiya Sasomsap that the country will continue to override
PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 11:25 A.M. (Local) MRS. BUSH: And for the press, adolescents with AIDS or are HIV positive are particularly difficult because it s hard to follow them to make sure they continue to come back as they re taking ARVs. And so I want to than
PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 10:55 A.M. (Local) MRS. BUSH: Well, one of the things I hope the American press hears from this -- the press from the United States that are here -- is that Haiti is a PEPFAR country, one of the targeted countries with PEPFAR funds. I t
PORT-AU-PRINCE, Haiti--GHESKIO HIV/AIDS Center Port-au-Prince, Haiti March 13, 2008 11:35 A.M. (Local) MRS. BUSH: We ve just been talking with women who, some of them, are HIV positive and have gone on antiretrovirals, and they start to feel good. And so they re ready to work and support their families. So they have go
MINNEAPOLIS--Minnesota AIDS Project, the leading source for HIV information and services in Minnesota, will bring together Minnesotans from all walks of life seeking to convey their concerns about HIV prevention and policy to their legislators on March 18. Attendees will meet with their elected representatives and rall
WASHINGTON--Global AIDS Alliance today released the following statement: Today, by an overwhelming majority, the Senate Foreign Relations Committee approved legislation that promises a major funding increase for AIDS, tuberculosis and malaria programs. The bill would authorize, though not appropriate, a total of $50 bi
WASHINGTON--This past week a delegation of 15 leading African health officials representing Ghana , Uganda , Tanzania , Kenya , Rwanda , Ethiopia , Zambia ,
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85751) has announced the addition of International Donor Funding for the Healthcare Industry in Key Sub-Saharan African Countries: Historical Data and Identified Ongoing Funding Sources to their offering. Africa, and in particular sub Sah
WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 65,000 individuals in 20 countries worldwide, expressed its profound disappointment with elements of a proposed bill (HR 5501) to reauthorize PEPFAR (the President s Emergency Plan for AIDS Relief), the successful
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85635) has announced the addition of Key Sub-Saharan African Infectious Disease Pharmaceutical Markets to their offering. This Frost & Sullivan research service titled Infectious Disease Pharmaceutical Markets in Key Sub-Saharan Afric
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c85326) has announced the addition of United States Pharmaceuticals & Healthcare Report Q1 2008 to their offering. The United States Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on t
CAPE TOWN, South Africa--Sizeable international funding is targeting the serious health challenges across sub-Saharan Africa. However, even as donors pledge significant amounts to AIDS, malaria and tuberculosis (TB) projects, information regarding the sources, values and destinations of the funding remain limited. New
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the 28th Annual Cowen Healthcare Conference to be held from March 17-20, 2008 at The Boston Marriott Copley Place. Dr. Alan W. Dunton, Pan
WASHINGTON--AIDS Healthcare Foundation (AHF), which provides AIDS care and treatment services to more than 62,000 individuals in 20 countries worldwide, will host a press teleconference on Monday, March 10th, at 10:30 AM (EDT), in which AHF s global medical providers and officials will comment on pending US legislation
WASHINGTON--Ronald Reagan Building Washington, D.C. 11:39 A.M. EST MRS. BUSH: Thank you very much, Henrietta. Thank you all, thanks so much. Thank you, and I m thrilled with the Laura W. Bush award that you ll be giving to State Department employees. Thank you very much for honoring me this way. I m really thrilled wit
RICHMOND, Va.--CBI Services, a business unit within the Commonwealth Biotechnologies, Inc. group of companies (NASDAQ Capital Market:CBTE), has been notified that its patent Detection and Quantification of Human Herpes Viruses was issued by the United States Patent and Trademark Office on March 4, 2008 as US Patent 7,3
GAITHERSBURG, Md.--GenVec, Inc. (Nasdaq:GNVC) announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH), to support the Company s efforts to develop novel adenovect
FORT WORTH, Texas--With a 130-percent increase in children and families served over the past five years and an economic forecast that promises even greater need, Catholic Charities Diocese of Fort Worth today announced plans to double its capacity to serve the working poor. The charity kicked off the public phase of Bu
Madison Square Garden, Monday, March 10, 2008 Event to Benefit The Dream Vaccines Foundation s Malaria Vaccine Initiative Inaugural Fundraising Event To Include Silent Auction NEW YORK--Dream Vaccines Foundation and Mymetics Corporation (OTCBB: MYMX), in association with the Marquis Jet Card and Men s Vogue, are proud
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that it has discovered factors that predict response to bevirimat, its lead HIV maturation inhibitor. In addition, it has completed a Phas
SAN RAMON, Calif.--Chevron Corp. (NYSE:CVX) today announced a new employee giving and volunteer program that will provide up to $20 million annually for U.S. nonprofit organizations. The new program, Chevron Humankind, includes company matching for employee financial contributions, grants to nonprofits for volunteer ti
BEVERLY HILLS, Calif.--Four major charities will share a $100,000 gift that Kathy has designated to celebrate record-setting sales her market-leading lifestyle products firm, Kathy Ireland Worldwide, achieved in 2007. Kathy named the Elizabeth Taylor HIV/AIDS Foundation, Alliance for Christian Education, Safe Surfing a
NYON, Switzerland--Mymetics Corporation (OTCBB: MYMX; http://www.mymetics.com), a biotechnology company focused on the development of protective mucosal antibody-based vaccines, hired the Investor Relations Group ( IRG ), a corporate communications firm based in New York City, to serve as its investor relations and fin
LAS VEGAS--Edward M. Bernstein & Associates, one of Nevada s leading Personal Injury Law Firms has been retained by former patients of the Endoscopy Center of Southern Nevada, who have in fact, tested positive for a Hepatitis C Infection in Las Vegas. The firm has filed individual lawsuits as well as a class action
* Free NurseLine services available for Southern Nevada residents * No out-of-pocket costs for UnitedHealth customers requiring testing * Working with network physicians to support timely access to testing LAS VEGAS--UnitedHealth Group (NYSE: UNH) and its family of companies are working in collaboration with the Southe
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c84627) has announced the addition of South Africa Pharmaceuticals and Healthcare Report Q1 2008 to their offering. The South Africa Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on South
ORANGEVALE, Calif.--Biomagnetics Diagnostics Corp. announced today a necessary review of its core technology. President Clayton Hardman felt it is important to expand on our last press release and point out the cost and practical advantage of our HTS-MTP diagnostics system. Today, the laboratory wholesale cost of a con
ALEXANDRIA, Va.--The National Association of State Boards of Education (NASBE) has made grants to three state boards of education to promote more effective instruction to K-12 students about HIV prevention. The $13,000 grants are being made to the North Carolina, Oregon, and Tennessee State Boards of Education. HIV rem
SCOTTSDALE, Ariz.--The Pharmacy Benefit Management Institute (PBMI) has awarded its 2008 Rx Benefit Innovation Awards to MemberHealth, LLC; Office of Group Benefits (OGB), State of Louisiana with Catalyst Rx, A HealthExtras Company; and the Upper Peninsula Health Plan with the Upper Peninsula Health Care Network. Membe
WASHINGTON--With a bipartisan voice vote earlier today, The House Foreign Affairs Committee today passed House Resolution 5501 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act), a bill to reauthorize the President s Emergency Plan for AIDS
WASHINGTON--As a fitting tribute to the late Committee Chairman Tom Lantos, Republicans and Democrats have crafted a bipartisan compromise to support AIDS, TB and malaria policy. The agreement will set US programs on a new five-year course. The bill was approved this morning at a House Foreign Relations Committee mark-
DURHAM, N.C.--Researchers at the Centre for Proteomics and Genomics Research (CPGR) in Cape Town, South Africa , have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan, including an HS 4800(trademark) Pro Hybridization Station with the new Qua
WASHINGTON--James S. Brady Press Briefing Room 12:43 P.M. EST MS. PERINO: Two statements for you. Today we learned that William F. Buckley has passed away and that has saddened everyone here at the White House. Mr. Buckley was a longtime friend of the Bush family. I informed the President of Mr. Buckley s death at 11:4
SASSARI, Italy & PRINCETON, N.J.--ViroStatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced the formation of a Scientific Advisory Board (SAB). Chaired by Daniel Kuritzkes, MD, Dir
OAKLAND, Calif.--The Flowers Heritage Foundation (FHF) Board of Directors today announced its appointment of Gregory W. Edwards, Ed.D. to the role of Executive Director. In this position, Dr. Edwards will be responsible for fundraising efforts and furthering the foundation s education and awareness programs, including
WASHINGTON--Marriott Wardman Park Hotel Washington, D.C. 9:48 A.M. EST THE PRESIDENT: Thanks for coming. I appreciate the warm welcome. Last Thursday Laura and I returned from a six-day visit to Africa. It happened to be her fifth visit, and my second. Without a doubt, this was the most exciting, exhilarating, upliftin
**12:00 pm ET**, Monday February 25 --Global AIDS Alliance: WHAT: A debate is raging about the next steps the US should take in addressing the global AIDS epidemic. On Wednesday February 27 the US House of Representatives will begin formal consideration of a law that will set US policy on AIDS, TB and malaria for the n
BOCA RATON, Fla.--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its wholly-owned medical devices subsidiary, Designer Diagnostics, has started marketing the first-ever environmental test kit for the detection of Nontuberculous
WASHINGTON--THE PRESIDENT: Good morning. This Thursday, Laura and I returned from an inspiring visit to Africa. In Benin and Tanzania , we met leaders who are fighting HIV/AIDS and malaria -- and people whose lives have been saved by the generosity of the American people. In Rwanda ,
NEW DELHI--A delegation from India s Coalition of AIDS Treatment Access (CATA), a diverse group of civil society partners who engage the collective advocacy interests of all the participating members towards better HIV/AIDS treatment, efficient treatment facilities and efficacy in treatment provision for people living
**12:00 pm ET**, Monday, February 25 Global AIDS Alliance: WHAT: A debate is raging about the next steps the US should take in addressing the global AIDS epidemic. On Wednesday February 27 the US House of Representatives will begin formal consideration of a law that will set US policy on AIDS, TB and malaria for the ne
WASHINGTON--In response to significantly different proposals by President Bush and Congress for the legislation to reauthorize the President s Emergency Plan for AIDS Relief (PEPFAR), the successful five-year-old US global AIDS program, AIDS Healthcare Foundation (AHF) (www.aidshealth.org) today unveils a new print ad
TULSA, Okla.--Geneva Global, the world s leading international philanthropic adviser, has deployed mobile technologies from Anyware Mobile Solutions to improve the collection of demographic and behavioral data in the effort to improve HIV/AIDS care and prevention in Ethiopia and Ivo
ACCRA, Ghana--Osu Castle Accra, Ghana 10:38 A.M. (Local) PRESIDENT KUFUOR: Mr. President, I believe we agreed to expose ourselves to the ladies and gentlemen of the media. (Laughter.) And so we are ready for your questions. PRESIDENT BUSH: Let me have a -- you want me to say something initially, Mr. President? PRES
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. Stakeholder Opinions: Hepatitis C - Small-molecule antivirals pave the way for triple therapy To order this report: www.reportlinker.com/p074963/2008/02/Stakeholder-Opinions- Hepa
ACCRA, Ghana--Aboard Air Force One En route Accra, Ghana 4:49 P.M. (Local) MS. PERINO: We are on our way to Ghana. The President had a very good day in Kigali. One thing to note, just now he spent about an hour with Sir Bob Geldof, who has been asked by Time Magazine and, I understand, maybe a couple of other publicati
OAKLAND, Calif.--Public Health Service Bureau today announced that the company has changed its name to Ramsell Public Health Rx to reflect its continued growth, and expansion to providing Pharmacy Benefit Management (PBM) solutions for the public health sector. With the introduction of its new PBM Solution, Ramsell Pub
SAN FRANCISCO--AGUILAS, a San Francisco-based Latino gay/bisexual non-profit organization offering programs focused on HIV/AIDS awareness, prevention, education, and outreach is holding a press conference Tuesday, February 19, 2008, 11 am PST, at Lesbian Gay Bisexual Transgender Community Center in San Francisco. The o
SACRAMENTO--AIDS Healthcare Foundation: WHAT: Assembly Health Hearing on STDs; & Media Availability Community Reaction to Hearing: California s Sexually Transmitted Disease Epidemic: Causes, Costs & Control WHEN: Tuesday, February 19th, 2:00pm - 4:00pm WHERE: STATE CAPITOL BUILDING, Room 4202, SACRAMENTO, CA
DAR ES SALAAM, Tanzania--Kilimanjaro Hotel Kempinski 3:09 P.M. (Local) MRS. BUSH: Since you all were with the President this morning, I d thought I d come tell you what I did with Madame Kikwete. MS. MCDONOUGH: And Nina could join us. MRS. BUSH: Oh, that s right. You were with us, so you heard everything. Today was a v
DAR ES SALAAM, Tanzania--Movenpick Royal Palm Hotel 4:15 P.M. (L) MS. PERINO: Hi, everybody. I will be happy to give you a little bit more about tomorrow and answer other questions after you have a chance to hear from the President s Global Aids Coordinator, who was with the President and Mrs. Bush today. He s traveled
DAR ES SALAAM, Tanzania--WAMA Foundation Dar es Salaam, Tanzania 10:46 A.M. (Local) MRS. BUSH: Thank you very much. Congratulations on this National Plan. (Applause.) I also want to thank the singers and the dancers from the Salvation Army for your great performance. Habari zako. (Applause.) Thank you for the warm welc
DAR ES SALAAM, Tanzania--BACKGROUND The President and Mrs. Bush will participate in a Tour of Amana District Hospital and Roundtable on PEPFAR Services. Amana District Hospital is a municipal hospital located in the Dar es Salaam city center. Amana serves a population of about 1 million people. It also serves as a refe
DAR ES SALAAM, Tanzania--State House Dar es Salaam, Tanzania 10:29 A.M. (L) PRESIDENT KIKWETE: Mr. President, welcome. I stand before you with a deep sense of gratitude and satisfaction to once again welcome you, Mr. President, and your entire delegation, to our dear country, Tanzania. (Applause.) The outpouring of war
WASHINGTON--Today President Bush and First Lady Laura Bush leave for a six-day visit to Africa to highlight the Administration s legacy in health, education and economic development. In a speech today, President Bush stated that his Administration has revolutionized the way we approach development by ending what he cal
WASHINGTON & BURBANK, Calif.--Warner Bros. Entertainment today announced a public-private partnership with the President s Emergency Plan for AIDS Relief (PEPFAR) to raise awareness about the global HIV/AIDS pandemic, and to collaborate on prevention efforts. The first product of the partnership between Warner Bros
WASHINGTON--Smithsonian National Museum of African Art 10:13 A.M. EST MRS. BUSH: Thank you very much, Mark. I get to speak first and introduce the President. Thank you, Mark, for your efforts to lead our country s efforts to defeat HIV/AIDS. Thank you very, very much for everything you do around the world. This is such
DALLAS--Next Tuesday s Dan Rather Reports travels to the Downtown-Eastside section of Vancouver, British Columbia - the single poorest neighborhood in Canada and one of the roughest areas in all of North America. In this section of the city, one in three residents is HIV positive. The rate of hepatitis C is 70 percent
WASHINGTON--James S. Brady Press Briefing Room--12:37 P.M. EST MR. HADLEY: Good afternoon. On Friday, the President and Mrs. Bush will travel to Africa. It will be his second visit to the continent since 2001, and Mrs. Bush s fifth visit. They will travel to Benin , Tanzania ,
PARIS--Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced results of the long-term follow-up of patients in a multi-center Phase I/II study designed to investigate the safety of Interleukin-7 (IL-7) therapy in chronically H
SAN FRANCISCO--AGUILAS, a San Francisco-based Latino gay/bisexual non-profit organization offering programs focused on HIV/AIDS awareness, prevention, education, and outreach is holding a press conference Tuesday, February 19, 2008, 11 am PST, at Lesbian Gay Bisexual Transgender Community Center in San Francisco. The o
SAN FRANCISCO--Presidio Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing novel, small molecule compounds for the treatment of HIV-1 and HCV and Numerate, Inc., a biotechnology company with a proprietary drug engineering platform, announced today that they have entered
NEW YORK--Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need To order this report: www.reportlinker.com/p074967/2008/02/08/Pipeline-Insight-HIV---Novel-NNRTIs-address-crucial-u
Valentines Day and National Condom Week Coincide, So What Better Gift for Your Valentine Than a Designer Novelty Gift for Cupid s Arrows at Work or Home From CondomPaperweights.com. DE SMET, S.D. -- Not sure what to get your sweetheart when Valentine s Day coincides with National Condom Week? Now you can clear the clut
WASHINGTON -- AIDS Healthcare Foundation (AHF) today called on Congress to reject a House bill to reauthorize the President s Emergency Plan for AIDS Relief (PEPFAR), the United States global AIDS treatment plan. The bill, which will be marked up by the Committee on Foreign Relations next week, eliminates a requirement
BETHLEHEM, Pa. -- OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today announced its support of National Black HIV/AIDS Awareness Day (NBHAAD), through the distribution of complimentary OraQuick ADVANCE(R) Rapid HIV-1/2 Antibody Test kits and educational materials to more than 25
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c82128) has announced the addition of Zimbabwe Pharmaceuticals and Healthcare Report Q3 2007 to their offering. The collapse of the Zimbabwean dollar, brought about by isolationist and internationally un
ATLANTA -- Inhibitex, Inc. (Nasdaq: INHX), a biopharmaceutical company focused on the development of novel antiviral agents, announced today that preclinical data relating to INH-001, one of several potential lead candidates from Inhibitex s HIV integrase inhibitor program, were presented during this week s 15th Annual
BOSTON -- In an unscientific study released today, Oxfam America found that the cutest possible Valentine s Day gift are a dozen baby chicks. The chicks, available as a symbolic gift from www.OxfamAmericaUnwrapped.com, have been shown to produce 57 percent more Awwwws than a dozen roses, and 85 percent more warm fuzzie
BOSTON -- At this week s major HIV/AIDS research meeting, Pfizer presented new data on two investigational second generation HIV compounds - a CCR5 antagonist and a non-nucleoside reverse transcriptase inhibitor (NNRTI). Pfizer also presented additional data on SelzentryTM (maraviroc) tablets, its first-in-class medici
BOSTON -- ISENTRESS(R) (raltegravir) tablets, Merck s HIV integrase inhibitor, in combination with other anti-HIV medicines, maintained significant HIV-1 viral load suppression and increased CD4 cell counts through 48 weeks of therapy compared to placebo in combination with anti-HIV medicines, in two Phase III studies
WATERTOWN, Mass.--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that its lead product candidate, the HIV maturation inhibitor bevirimat (PA-457), was the subject of two presentations at the 15th Confere
PORTLAND, Ore. -- Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced the first sale of its Aware(TM) HIV-1/2 OMT rapid oral fluid test in India . The tests were purchased by one of the paramilitary forces of the Government of India. Roger I.
MINNEAPOLIS--HIV remains a serious public health issue in the United States and in Minnesota. As the Minnesota AIDS Project recognizes its 25th year of service, it is also essential to acknowledge the continuing disparity in HIV rates within the African American community. On February 7, 2008, organizations throughout
WASHINGTON -- I congratulate President Jakaya Kikwete of Tanzania on his appointment as the new President of the African Union, as well as Foreign Minister Jean Ping of Gabon on his appointment as the new Chair of the Commission of the African Union. I am confident that the African Union -- and the people of Africa --
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c81703) has announced the addition of Handbook of Prevention and Intervention Programs for Adolescent Girls to their offering. A contemporary look at the best programs and most positive approaches that work with adolescent girls toda
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c81617) has announced the addition of Comprehensive Textbook of AIDS Psychiatry to their offering. Among the vast and rapidly growing field of AIDS research, there is an ample body of evidence supporting the fact that psychiatric treatme
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c81552) has announced the addition of Datamonitor s new report: Pipeline Insight: HIV - Novel NNRTIs address crucial unmet need to their offering. Treatment of HIV has come a long way since the discovery of the virus.
Office of AIDS Programs and Policy: WHAT: A Rally/Human Billboard will take place for National Black HIV/AIDS Awareness Day on February 7. The goal of the Rally/Human Billboard along with FREE HIV testing is to help bring attention to the devastating affects of HIV/AIDS on the African-American community. Speakers at th
WASHINGTON -- On Thursday February 7 the US Congress will take the first step in determining US policy on global HIV/AIDS for the next five years. The US has committed to the international goal of universal access to all HIV/AIDS services by 2010 and to halting and reversing the AIDS epidemic by 2015. Congress will hav
WASHINGTON -- AIDS Healthcare Foundation (AHF) (http://www.aidshealth.org) today blasted President George W. Bush for his neglect of the domestic AIDS epidemic in his proposed AIDS funding allocations in the fiscal year 2009 budget. The two principal AIDS programs funded by the federal government, the AIDS Drug Assista
STANFORD, Calif. -- Stanford Blood Center is deeply disappointed in San Jose State University President Don Kassing s decision to suspend blood drives on campus out of a concern that a federal policy regarding blood donor eligibility is discriminatory. This is a terribly misguided tactic that could have a devastating i
Company Announces Full-Year 2007 Non-GAAP EPS of $3.20 and Fourth-Quarter Non-GAAP EPS of $0.80, Excluding Certain Previously Disclosed Items; Full-Year GAAP EPS of $1.49 and Fourth-Quarter GAAP EPS of $(0.75) **get table
PORTLAND, Ore. -- Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today launched its latest new product, Aware Messenger(TM), an oral fluid sample collection device for collecting high-quality oral fluid specimens for high-throughput laboratory testing. We
DURHAM, N.C. -- Argos Therapeutics today announced the publication of an article in the peer-reviewed online journal PLoS ONE supporting the company s novel approach to stimulating a patient-specific immune response to HIV infection. The present study describes the adaptation of Argos proprietary Arcelis(TM) technology
MORRISVILLE, N.C. -- Trimeris, Inc. today announced worldwide net sales of FUZEON for the year were $266.8 million, an increase of 7 percent from $249.0 million in 2006. Net sales of FUZEON in the U.S. and Canada for 2007 were $124.3 million, down 7 percent from $134.2 million in 2006. Net sales of FUZEON outside the U
MCALLEN, Texas -- Medical Safety Technologies, Inc. (MST), a designer and supplier of medical devices solving safety issues related to needle stick injuries, introduces its new TurtleTM SafeShot Safety Syringe, the only passive, self-sheathing syringe never exposing the needle during the entire injection process. Unlik
WASHINGTON -- AIDS Healthcare Foundation (AHF) (www.aidshealth.org) commended President Bush for his call to extend for five years the global AIDS initiative PEPFAR (President s Emergency Plan for AIDS Relief) and to increase funding for the program, made during his final State of the Union address earlier tonight. Dur
NORTHAMPTON, Mass. -- The Safe Haven Project, Inc. announced today that it has received a $25,000 grant from the MAC AIDS Fund, the philanthropic arm of Estee Lauder-owned (NYSE: EL) MAC Cosmetics to support the second in a series of three HIV education tours throughout Ghana from January 31 through February 14, 2008.
WASHINGTON -- Global Aids Alliance stated today that in tonight s State of the Union Address, President Bush is expected to highlight some of his signature initiatives on global poverty, such as the global AIDS program (PEPFAR) and the Millennium Challenge Account. In mid-February he plans to visit several African nati
PORTLAND, Ore. -- Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that the Chinese State Food and Drug Administration ( SFDA ) has notified Calypte s Chinese manufacturing subsidiary, Beijing Marr Bio-pharmaceutical Co., Ltd., ( Beijing Marr
FOSTER CITY, Calif. -- Gilead Sciences , Inc. announced today its results of operations for the fourth quarter and full year of 2007. Total revenues for the fourth quarter of 2007 were $1.09 billion, up 22 percent compared to total revenues of $899.2 million for the fourth quarter of 2006. Full year 2007 total revenues
DEERFIELD, Ill. -- OVATION Pharmaceuticals, Inc. announced today that Sabril(R) (vigabatrin) has received Fast Track designation from the U.S. Food and Drug Administration ( FDA ), potentially expediting development of this novel compound that is being evaluated for the treatment of cocaine and methamphetamine dependen
GENEVA, Switzerland & SAN RAMON, Calif. -- The Global Fund to Fight AIDS, TB and malaria today announced the launch of The Global Fund Corporate Champions program, an innovative way for multinational corporations to significantly invest in the fight against the three diseases. Chevron Corporation (NYSE:CVX) is
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79845) has announced the addition of Scrip Yearbook 2007: 23rd Edition (2 Volumes) to their offering. Scrip s annual review of the year, Scrip Yearbook 2007, is your guide to all the key facts, events and issues of the last 12 months fr
LAS VEGAS -- Today, an HIV prognosis comes with an array of possible treatment choices rather than the death sentence it used to hold. While the word treatment is liberating to hear for HIV patients, the drugs that are used to combat this chronic disease are replete with a myriad of serious side effects such as kidney
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79871) has announced the addition of Peripheral Neuropathy and Neuropathic Pain to their offering. Report Description: This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals
NEW YORK -- Pfizer Inc today announced the eighth class of Global Health Fellows, a group of 28 Pfizer colleagues from North America, Europe and Asia, who will partner with non-governmental organizations (NGOs) and multilateral organizations (MLOs) in developing countries to help build health care infrastructure while
TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the initiation of the phase 2 clinical program for PRO 140, an investigational drug for the treatment of human immunodeficiency virus (HIV) infection. Two, phase 2 clinical trials in HIV-infected individuals will investigate multiple dose
CARY, N.C. & BIRMINGHAM, Ala. -- Trana Discovery, a drug discovery technology company, today announced that their recently-developed HIV high-throughput screening (HTS) assay designed to identify compounds that inhibit the use of transfer RNA (tRNA) by HIV has the ability to select compounds with anti-HIV bioactivi
LOS ANGELES -- AIDS Healthcare Foundation (AHF), today expressed concern over a recent study first reported publicly today in an Annals of Internal Medicine article which found that sexually active gay men in San Francisco were 13 times as likely to contract methicillin-resistant Staphylococcus aureus (MRSA), a drug-re
STOCKHOLM, Sweden & PITTSBURGH -- Regulatory News: Diamyd Medical AB (www.omxgroup.com) (NASDAQ:DMYDY) (STO:DIAMB): Diamyd Medical announces that it is submitting an IND today for NP2, the company s first drug candidate in its Nerve Targeting Drug Delivery System (NTDDS) gene therapy platform, to the US Food and Dr
LOS ANGELES -- AIDS Healthcare Foundation (AHF) today welcomed the news of a Harvard study, published in Thursday s issue of the journal Science, identifying 237 previously-undiscovered proteins the AIDS virus exploits to enter human cells and reproduce. The findings could open up new avenues of drug development. Curre
STOCKHOLM, Sweden -- Regulatory News: Medivir AB (STO:MVIRB) announced today that their research development and license agreement, in the field of HIV- protease inhibitors , with Tibotec Pharmaceuticals Ltd. is extended for a further year and includes research funding. The programme is presently in preclinical researc
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c78682) has announced the addition of “HIV Vaccine Update: R&D Innovation Critical in the Wake of Recent Setbacks” to their offering. Introduction Despite 25 years of extensive research, an HIV vaccine remains an elusive target.
WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the 26th Annual JPMorgan Healthcare Conference to be held from January 7-10, 2008 at The Westin St. Francis, San Francisco, CA. Dr. Alan
MELBOURNE, Australia -- Biotechnology company Avexa Limited (ASX:AVX) announced today that it has initiated the Phase III program for apricitabine (ATC), its anti-HIV drug. The Company recently received positive feedback from regulatory agencies allowing ATC s progress into pivotal, filing studies. The Phase III tr
BETHLEHEM, Pa. -- OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, is pleased to announce that Debra Fraser-Howze, current President/CEO of the National Black Leadership Commission on AIDS (NBLCA), will join the Company as Vice President, Government and External Affairs on January
This information is designed to support, not replace, the relationship that exists between you and your doctor.